| 1 |
LumateperoneM/s IQVIA RDS
|
|
249 KB
|
| 2 |
Golcadomide (BMS- 986369/CC -99282)
|
|
252 KB
|
| 3 |
BI 690517
|
|
252 KB
|
| 4 |
LNP023 (Iptacopan)
|
|
244 KB
|
| 5 |
Amivantamab
|
|
257 KB
|
| 6 |
Barzolvolimab (CDX-0159)
|
|
293 KB
|
| 7 |
SAR443765 solution for injection 165mg/1.1 mL (150mg/mL)
|
|
286 KB
|
| 8 |
Carbetocin RTS
|
|
243 KB
|
| 9 |
Pembrolizumab (BAT3306)
|
|
252 KB
|
| 10 |
"GME751 (pembrolizumab) concentrate for solution for infusion 25 mg/mL (100 mg/vial)"
|
|
263 KB
|
| 11 |
SAR445229 /amlitelimab
|
|
287 KB
|
| 12 |
BI 456906 solution for injection 0.5 ml
|
|
255 KB
|
| 13 |
AZD0901 Powder for solution for infusion (50 mg/vial)
|
|
247 KB
|
| 14 |
Astegolimab (RO7187807)
|
|
296 KB
|
| 15 |
AZD5462
|
|
254 KB
|
| 16 |
Budesonide++Glycopyrronium+ Formoterol fumarate (BGF)
|
|
255 KB
|
| 17 |
Miricorilant
|
|
|
| 18 |
BI 690517
|
|
|
| 19 |
Trospium chloride+Xanomeline tartrate
|
|
250 KB
|
| 20 |
Clascosterone cream 1% w/w
|
|
3661 KB
|
| 21 |
Lumateperone Capsules 42 mg
|
|
903 KB
|
| 22 |
GZ402671/venglustat
|
|
286 KB
|
| 23 |
Olezarsen (ISIS 678354)M/s. Medpace Clinical
|
|
286 KB
|
| 24 |
Olezarsen (ISIS 678354)
|
|
286 KB
|
| 25 |
PF-07899801 or Rimegepant
|
|
245 KB
|
| 26 |
Etavopivat
|
|
251 KB
|
| 27 |
Esaxerenone Tablets 5.0mg
|
|
835 KB
|
| 28 |
Balcinrenone 15 mg+Dapagliflozin 10 mg
|
|
259 KB
|
| 29 |
SKB264 2870
|
|
246 KB
|
| 30 |
Etavopivat 200mg/ PlaceboM/s Novo Nordisk
|
|
251 KB
|
| 31 |
Avibactam 0.5 g + Aztreonam 1.5 g Powder for Concentrate for Solution for Infusion
|
|
247 KB
|
| 32 |
PLN-74809
|
|
250 KB
|
| 33 |
LY3537982
|
|
261 KB
|
| 34 |
BI 690517
|
|
263 KB
|
| 35 |
Anifrolumab (MEDI-546) Solution for injection
|
|
249 KB
|
| 36 |
EFRUXIFERMIN (EFX)
|
|
261 KB
|
| 37 |
Dexpramipexole dihydrochloride monohydrate
|
|
261 KB
|
| 38 |
Cenobamate
|
|
251 KB
|
| 39 |
Datopotamab deruxtecan (DS-1062a) 100mg/ vial; 2. Rilvegostomig (AZD2936) 750mg/vial (50mg/ml)
|
|
252 KB
|
| 40 |
BMS-986278 c
|
|
260 KB
|
| 41 |
Baxdrostat Tablets 1mg/ 2mg/Placebo,
|
|
249 KB
|
| 42 |
Cagrilintide+Semaglutide
|
|
248 KB
|
| 43 |
LY3437943
|
|
250 KB
|
| 44 |
TIN816
|
|
274 KB
|
| 45 |
Olsalazine
|
|
1827 KB
|
| 46 |
Tedizolid phosphate Tablets and Injection
|
|
2124 KB
|
| 47 |
BAY 3283142
|
|
677 KB
|
| 48 |
OAV101Novartis Healthcare
|
|
668 KB
|
| 49 |
AVIPTADIL INJECTIONI 150UG/10MLCT/SND/14/2024
|
|
1523 KB
|
| 50 |
OAV101
|
|
668 KB
|
| 51 |
Luspatercept
|
|
667 KB
|
| 52 |
Mezigdomide (CC-92480)
|
|
686 KB
|
| 53 |
BMS-986278
|
|
704 KB
|
| 54 |
Amoxicillin Trihydrate IP eq. to Amoxicillin USP 600mg + Potassium Clavulanate diluted IP eq. to Clavulanic Acid 42.9mg per 5ml powder for reconstitution into suspension
|
|
4710 KB
|
| 55 |
VAY736 (Ianalumab)
|
|
667 KB
|
| 56 |
Dostarlimab, Belrestotug
|
|
697 KB
|
| 57 |
SAR441344 /frexalimab1
|
|
691 KB
|
| 58 |
CagriSema
|
|
682 KB
|
| 59 |
Glycopyrrolate IP eq. to Glycopyrronium 25mcg + Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumarate 20mcg + Budesonide IP 0.5mg inhalation suspension
|
|
6827 KB
|
| 60 |
Volrustomig (MEDI5752) Lyophilized product for concentrate for solution for infusion 250 mg/vial (50mg/mL)
|
|
679 KB
|
| 61 |
Etavopivat 200mg
|
|
659 KB
|
| 62 |
Retatrutide
|
|
720 KB
|
| 63 |
DeucravacitinibBristol-Myers Squibb
|
|
638 KB
|
| 64 |
NNC0519-0130
|
|
642 KB
|
| 65 |
lepodisiran sodium (LY3819469)
|
|
675 KB
|
| 66 |
SKB264 (MK-2870)
|
|
641 KB
|
| 67 |
Plazomicin injection 500 mg/10mL
|
|
2261 KB
|
| 68 |
Repotrectinib ( BMS-986472,TPX-0005)
|
|
681 KB
|
| 69 |
Deucravacitinib
|
|
683 KB
|
| 70 |
REGN7999
|
|
643 KB
|
| 71 |
SAR441344 /frexalimab
|
|
649 KB
|
| 72 |
Cilnidipine IP 20mg + Telmisartan IP 40mg film coated tablet
|
|
6282 KB
|
| 73 |
PY test Kit Carbon 14 Urea Capsule
|
|
898 KB
|
| 74 |
Asciminib tablets
|
|
572 KB
|
| 75 |
Relugolix Tablets
|
|
874 KB
|
| 76 |
Gefapixant tablets
|
|
1109 KB
|
| 77 |
Clascosterone and minoxidil Topical Solution Clascosterone and latanoprost Topical Solution
|
|
10385 kb
|
| 78 |
Relugolix 40mg + Estradiol USP (as hemihydrate) eq. to Estradiol 1mg + Norethindrone Acetate USP 0.5mg film coated tablets
|
|
5218 KB
|
| 79 |
SEMAGLUTIDE INJECTION 2MG/1.5MLCT/SND/13/2024
|
|
1573 KB
|
| 80 |
13-valent Pneumococcal Polysaccharide Conjugate Vaccine (TT/DT)
|
|
218 KB
|
| 81 |
BI 1015550 9 mg & BI 1015550 18 mg
|
|
633 KB
|
| 82 |
56 film coated tablets of BI 1015550 9 mg OR 56 film coated tablets of BI 1015550 18 mg
|
|
633 KB
|
| 83 |
Remifentanil Hydrochloride 1mg/2mg for injection
|
|
1018 KB
|
| 84 |
Indacaterol (as Indacaterol acetate) 150mcg + Glycopyrronium (As Glycopyrrolate IP) 50mcg + Mometasone Furoate IP 160mcg powder for inhalation in capsule
|
|
5820 KB
|
| 85 |
CT-08-2024 GSK
|
|
1668 KB
|
| 86 |
Zibotentan
|
|
773 KB
|
| 87 |
Human cell line recombinant Factor VIII
|
|
553 KB
|
| 88 |
MORF-057
|
|
704 KB
|
| 89 |
MORF-057M/s PSI CRO
|
|
704 KB
|
| 90 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Glimepiride IP + Metformin Hydrochloride (As ER) (10mg + 1mg + 1000mg & 10mg + 2mg + 1000mg) film coated tablets
|
|
6423 KB
|
| 91 |
CT-07-2024 Zydus
|
|
213 KB
|
| 92 |
LEE011M/s Novartis Healthcare
|
|
656 KB
|
| 93 |
Live-Attenuated Respiratory Syncytial Virus (RSV) âNS2/â1313/I1314L vaccine (RSVt vaccine)
|
|
672 KB
|
| 94 |
LEE011
|
|
656 KB
|
| 95 |
LOU064 (Remibrutinib)
|
|
664 KB
|
| 96 |
Zanidatamab (ZW25 and JZP598)
|
|
669 KB
|
| 97 |
CT-06 2024 Bio.E
|
|
414 KB
|
| 98 |
ELIGLUSTAT SUBLINGUAL FILCT/SND/12/2024
|
|
1564 KB
|
| 99 |
elmisartan IP + Amlodipine Besilate IP eq .to Amlodipine + Bisoprolol Fumarate IP (40mg + 5mg + 2.5mg & 40mg + 5mg + 5mg) film coated tablets
|
|
5831 KB
|
| 100 |
Dexamethasone (1.5% w/v)
|
|
574 KB
|
| 101 |
Dexamethasone (1.5% w/v)
|
|
574 KB
|
| 102 |
Tafenoquine 50mg and 150 mg Tablets
|
|
2205 KB
|
| 103 |
LNP023
|
|
664 KB
|
| 104 |
LNP023
|
|
664 KB
|
| 105 |
TEMOZOLOMIDE POWDER FOR ORAL SUSPENSION 20MG/ML (300MG/15ML)CT/SND/10/2024
|
|
1499 KB
|
| 106 |
CYCLOPHOSPHAMIDE POWDER FOR ORAL SOLUTION 30MG/MCT/SND/08/2024
|
|
1603 KB
|
| 107 |
Polmacoxib Capsules 2mg
|
|
2293 KB
|
| 108 |
CT-05 2024 TB
|
|
714 KB
|
| 109 |
Dexamethasone (1.5% w/v)
|
|
648 KB
|
| 110 |
Omalizumab
|
|
679 KB
|
| 111 |
Omalizumab
|
|
649 KB
|
| 112 |
Empagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (10mg + 100mg & 25mg + 100mg) film coated tablet
|
|
5445 KB
|
| 113 |
Glycopyrronium Bromide (Eq. to 50mcg of Glycopyrronium) (63mcg) + Vilanterol Trifenatate (Eq. to 25mcg Vilanterol) (40mcg) powder for inhalation in capsules
|
|
5100 KB
|
| 114 |
Leuprolide acetate for injectable suspension
|
|
782 KB
|
| 115 |
PF-07220060 100mg Tablets
|
|
656 KB
|
| 116 |
VAY736 (Ianalumab)
|
|
639 KB
|
| 117 |
REGN3500 (Itepekimab) 300 mg (150 mg/mL) Solution
|
|
654 KB
|
| 118 |
ALT-803 (N-803)
|
|
680 KB
|
| 119 |
GSK4057190A/Dostarlimab
|
|
696 KB
|
| 120 |
PF 06463922 Lorlatinib 25mg Tablets
|
|
634 KB
|
| 121 |
Osivelotor
|
|
671 KB
|
| 122 |
Bedaquiline, Rifampicin, Clofazimine, Dapsone
|
|
674 KB
|
| 123 |
Baxdrostat Tablets, Baxdrostat Tablets 1mg/ 2mg/Placebo, Dapagliflozin Tablets 10 mg, Baxdrostat Tablets 1mg/ 2mg/Placebo, Dapagliflozin Tablets 10 mg, Baxdrostat Tablets 1mg/ 2mg/Placebo, Dapagliflozin Tablets 10 mg
|
|
697 KB
|
| 124 |
Cannabidiol 100mg/ml Oral Solution
|
|
1051 KB
|
| 125 |
Ziltivekimab C 30 mg/ml / placebo
|
|
831 KB
|
| 126 |
Entrectinib Capsules 100mg and 200mg
|
|
1063 KB
|
| 127 |
Lobeglitazone Sulfate 0.5mg + Glimepiride 1mg Tablets
|
|
1083 KB
|
| 128 |
Crisaborole Ointment 2%
|
|
1285 KB
|
| 129 |
Volrustomig (MEDI5752)
|
|
758 KB
|
| 130 |
Ravulizumab 10mg/mL (300mg/ 30mL) or Placebo
|
|
692 KB
|
| 131 |
Insulin icodec 700 U/ml
|
|
746 KB
|
| 132 |
AP063
|
|
456 KB
|
| 133 |
SAR445229 / amlitelimab
|
|
746 KB
|
| 134 |
Luspatercept (ACE-536)
|
|
740 KB
|
| 135 |
DIPEROXOCHLORIC ACID TOPOCAL SOLUTION 1.16MGCT/SND/25/2023
|
|
1572 KB
|
| 136 |
Moxifloxacin Hydrochloride IP eq. to Moxifloxacin 0.5%w/v + Nepafenac 0.1%w/v + Benzalkonium Chloride IP 0.01%v/v (as preservative) Ophthalmic Solution
|
|
5707 KB
|
| 137 |
Relugolix,Estradiol and Norethindrone Acetate Tablets
|
|
1904 KB
|
| 138 |
Inclisiran solution for injection in Prefilled syringe 284mg/1.5ml
|
|
1334 KB
|
| 139 |
DRL_AB
|
|
547 KB
|
| 140 |
Tildrakizumab
|
|
520 KB
|
| 141 |
Tildrakizumab Injection 100 mg/ ml
|
|
502 KB
|
| 142 |
RITLECITINIB
|
|
657 KB
|
| 143 |
Durvalumab versus Sunitinib
|
|
554 KB
|
| 144 |
ISB 2001
|
|
655 KB
|
| 145 |
Dydrogesterone IP 2.5mg + Estradiol EP 0.5mg tablets
|
|
5004 KB
|
| 146 |
Benralizumab
|
|
557 KB
|
| 147 |
AMISULPRIDE 5MG/2MCT/SND/04/2024
|
|
1485 KB
|
| 148 |
GIREDESTRANT
|
|
671 KB
|
| 149 |
AZD5305
|
|
689 KB
|
| 150 |
CABAZITAXEL TABLETS 50MGCT/SND/05/2024
|
|
322 KB
|
| 151 |
AKP02G2
|
|
657 KB
|
| 152 |
Typhoid Vi Conjugate Vaccine (Typhoid (Vi Capsular Polysaccharide) - Tetanus Toxoid Conjugate Vaccine)
|
|
284 KB
|
| 153 |
Fluticasone Furoate 100mcg + Glycopyrronium Bromide Ph. Eur eq. to Glycopyrronium 50mcg + Vilanterol Trifenatate
|
|
215 KB
|
| 154 |
Romiplostim 250µg/0.5mL
|
|
568 KB
|
| 155 |
Ustekinumab 45mg/0.5mL
|
|
700 KB
|
| 156 |
Filgrastim 300mcg/0.5ml
|
|
698 KB
|
| 157 |
Brexpiprazole 1mg/2mg/3mg/4mg Tablets
|
|
1310 KB
|
| 158 |
iptacopan (LNP023)
|
|
654 KB
|
| 159 |
Sisunatovir
|
|
666 KB
|
| 160 |
cagrilintide and semaglutide (CagriSema) 2.4mg/2.4mg s.c.
|
|
749 KB
|
| 161 |
Bevacizumab 25 mg/mL
|
|
706 KB
|
| 162 |
Belantamab Mafodotin
|
|
569 KB
|
| 163 |
BION-1301
|
|
685 KB
|
| 164 |
Datopotamab Deruxtecan (Dato-DXd)
|
|
688 KB
|
| 165 |
Dengue Tetravalent Vaccine, Live Attenuated (Recombinant, Lyophilized)
|
|
350 KB
|
| 166 |
ziltivekimab
|
|
805 KB
|
| 167 |
Rusfertide (PTG-300)
|
|
652 KB
|
| 168 |
Datopotamab Deruxtecan (Dato-DXd)100mg/vial,Durvalumab (MEDI4736) 500mg/vial
|
|
766 KB
|
| 169 |
ALXN1850
|
|
657 KB
|
| 170 |
AZD4604
|
|
672 KB
|
| 171 |
Varicella Zoster Virus (VZV) Vaccine
|
|
283 KB
|
| 172 |
Bevacizumab Injection 1.25 mg
|
|
719 KB
|
| 173 |
CEFEPIME-ZIDEBACTAM (FEP-ZID) WCK5222
|
|
660 KB
|
| 174 |
KLU156 with Coartem®
|
|
655 KB
|
| 175 |
PANTOPRAZOLE
|
|
659 KB
|
| 176 |
Test Formulation A: Dutasteride 0.05% w/w + Minoxidil 5% w/w & Test Formulation B: Dutasteride 0.05% w/w + Latanoprost 0.03% w/w
|
|
361 KB
|
| 177 |
Vilanterol Trifenatate eq. to Vilanterol 25mcg + Glycopyrrolate IP eq. to Glycopyrronium 50mcg + Fluticasone Furoate 200mcg powder for inhalation in capsule
|
|
358 KB
|
| 178 |
Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA), Inactivated Poliomyelitis and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed)
|
|
311 KB
|
| 179 |
NIMESULIDE GRANULES FOR ORAL SUSPENSION 100MG CT/SND/02/2024
|
|
1943 KB
|
| 180 |
Pembrolizumab
|
|
684 KB
|
| 181 |
tocilizumab biosimilar (DRL_Tocilizumab)
|
|
662 KB
|
| 182 |
Curcumin (Biocurcumax capsule)
|
|
875 KB
|
| 183 |
ISB 1442
|
|
713 KB
|
| 184 |
Denosumab (Bmab 1000) 120mg/1.7mL
|
|
668 KB
|
| 185 |
Budesonide, Glycopyrronium, and Formoterol Fumarate (BGF)
|
|
671 KB
|
| 186 |
Camizestrant (AZD9833
|
|
695 KB
|
| 187 |
Fexuprazan Tablets
|
|
1408 KB
|
| 188 |
Dupilumab 150 mg/mL
|
|
995 KB
|
| 189 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Empagliflozin (100mg + 25mg & 100mg +10mg) film coated tablets
|
|
294 KB
|
| 190 |
Moxifloxacin Hydrochloride IP eq. to Moxifloxacin 0.5%w/v + Nepafenac 0.1%w/v + Benzalkonium Chloride Solution IP 0.01%v/v
|
|
285 KB
|
| 191 |
ARTEMIDE-Biliary01GCT/CT04/FF/2023/39848 CT/23/0001222
|
|
750 KB
|
| 192 |
GIREDESTRANT
|
|
671 KB
|
| 193 |
GABAPENTINE ER TABLETS 300MG/600MGCT/SND/03/2024
|
|
2261 KB
|
| 194 |
Empagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IPd
|
|
339 KB
|
| 195 |
Lupin Denosumab 60mg/mL
|
|
883 KB
|
| 196 |
Brentuximab Vedotin 50mg
|
|
562 KB
|
| 197 |
cetirizine ophthalmic solution 0.24% w/vct/snd/01/2024
|
|
1928 KB
|
| 198 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Linagliptin + Metformin Hydrochloride IP(10mg + 5mg + 500mg & 10mg + 5mg + 1000mg film coated tabletss
|
|
340 KB
|
| 199 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg + Sacubitril and Valsartan as Sodium salt complex 200mg (97mg and 103mg)
|
|
425 KB
|
| 200 |
Vonoprazan Fumarate 20 mg Tablets
|
|
1085 KB
|
| 201 |
IBERDOMIDE, DARATUMUMAB AND DEXAMETHASONE (IBERDD)
|
|
668 KB
|
| 202 |
Eluxadoline Tablets
|
|
1999 KB
|
| 203 |
Efonidipine Hydrochloride Ethanolate 40mg + Telmisartan IP 40mg uncoated bilayered tablets
|
|
280 KB
|
| 204 |
Insulin Aspart Mix 30, 100IU/mL
|
|
735 KB
|
| 205 |
Triafarotene 50 µg/g Cream
|
|
1812 KB
|
| 206 |
Niraparib Tablets 100 mg
|
|
1940 KB
|
| 207 |
Upadacitinib Extednded Release Tablets
|
|
1972 KB
|
| 208 |
Gabapentin IP (as sustained release) + Methylcobalamin IP + Nortriptyline Hydrochloride IP eq. to Nortriptylinefilm coated bilayered tablets (Phase III)
|
|
311 KB
|
| 209 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Telmisartan IP (10mg + 40mg & 10mg + 80mg tablets
|
|
280 KB
|
| 210 |
Empagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP
|
|
278 KB
|
| 211 |
Empagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (10mg + 100mg & 25mg + 100mg) film coated tablets
|
|
295 KB
|
| 212 |
Gabapentin IP (as film coated tablets) + Duloxetine Hydrochloride IP eq. to Duloxetine (as delayed release pellets) (300mg + 30mg & 200mg + 20mg)
|
|
282 KB
|
| 213 |
Silodosin JP 8mg (as film coated tablet) + Tadalafil IP 5mg (as film coated tablet) hard gelatin capsules (Phase III)
|
|
301 KB
|
| 214 |
PHESGO
|
|
790 KB
|
| 215 |
Dostarlimab, 500mg/10mL
|
|
814 KB
|
| 216 |
DEGLUSTEROL ON FASTING GLUCOSE
|
|
652 KB
|
| 217 |
Abatacept biosimilar (DRL_AB) with Orencia
|
|
671 KB
|
| 218 |
Ambrisentan
|
|
272 KB
|
| 219 |
Capivasertib plus CDK4/6
|
|
693 KB
|
| 220 |
Sibeprenlimab
|
|
684 KB
|
| 221 |
SB27 (proposed pembrolizumab biosimilar) and Keytruda
|
|
662 KB
|
| 222 |
Remibrutinib 25 mg b.i.d.
|
|
681 KB
|
| 223 |
BI456906
|
|
675 KB
|
| 224 |
abeLacimab
|
|
690 KB
|
| 225 |
Mim8
|
|
672 KB
|
| 226 |
DEGLUSTEROL
|
|
657 KB
|
| 227 |
Linagliptin + Metformin Hydrochloride IP (as extended release) (2.5mg + 1000mg & 5mg + 1000mg) film coated bilayered tablet
|
|
331 KB
|
| 228 |
SARS-CoV-2 (Covid-19) Vaccine (Variant XBB.1.5)
|
|
324 KB
|
| 229 |
Mycobacterium Tuberculosis (Live, Attenuated) Vaccine
|
|
414 KB
|
| 230 |
Golimumab 50mg/0.5mL
|
|
1098 KB
|
| 231 |
Biphasic Isophane Insulin Injection IP 100IU/ml (30% soluble insulin/ 70% isophane insulin)
|
|
718 KB
|
| 232 |
101-PGC-005005CT/ND/45/2023
|
|
883 KB
|
| 233 |
101-PGC-005
|
|
829 KB
|
| 234 |
CagriSema s.c. in doses 2.4/2.4 mg
|
|
346 KB
|
| 235 |
AnifrolumabAs
|
|
687 KB
|
| 236 |
Iberdomidebri
|
|
674 KB
|
| 237 |
Vilanterol Trifenatate eq. to Vilanterol 12.5mcg + Glycopyrrolate IP eq. to Glycopyrronium 25mcg + Fluticasone Furoate 100mcg metered dose inhalation
|
|
275 KB
|
| 238 |
Cilnidipine IP 10mg + Bisoprolol Fumarate IP 5mg film coated tablet
|
|
206 KB
|
| 239 |
Zinc chloride Ph. Eur. 1050 mcg + Sodium fluoride Ph. Eur. 210.0 mcg + Potassium iodide Ph. Eur. 16.60 mcg
|
|
2187 KB
|
| 240 |
Yellow Fever Vaccine (Live) I.P.
|
|
284 KB
|
| 241 |
spesolimab i.v
|
|
657 KB
|
| 242 |
Afimetoran
|
|
657 KB
|
| 243 |
Volrustomig
|
|
687 KB
|
| 244 |
Pretomanid BJ
|
|
652 KB
|
| 245 |
CBT-001
|
|
673 KB
|
| 246 |
JNJ-77242113
|
|
658 KB
|
| 247 |
iptacopan
|
|
657 KB
|
| 248 |
Rusfertide PTG-300
|
|
670 KB
|
| 249 |
FXIa inhibitor asundexianBAY 2433334
|
|
562 KB
|
| 250 |
Dengue Tetravalent Vaccine (Live, Attenuated) Serum
|
|
319 KB
|
| 251 |
Durvalumab
|
|
652 KB
|
| 252 |
Varicella Vaccine (Live, Attenuated)
|
|
427 KB
|
| 253 |
Tozorakimabdec
|
|
674 KB
|
| 254 |
Acebrophylline 100mg + Erdosteine 300mg film coated tablets
|
|
305 KB
|
| 255 |
Gabapentin USP 6.0%w/w + Lidocaine HCl IP eq. to Lidocaine 5.0%w/w gel
|
|
289 KB
|
| 256 |
Zetomipzomib KZR-616 30 mg or 60
|
|
802 KB
|
| 257 |
CRN04894dec
|
|
660 KB
|
| 258 |
Pegozafermin
|
|
677 KB
|
| 259 |
Pregabalin IP (as granules) + Duloxetine hydrochloride IP+ Methylcobalamin IP (as granules)hard gelatin capsule
|
|
305 KB
|
| 260 |
Camizestrant AZD9833
|
|
695 KB
|
| 261 |
Denosumab 120mg/1.7mL
|
|
736 KB
|
| 262 |
EYU688
|
|
654 KB
|
| 263 |
remibrutinib LOU064
|
|
700 KB
|
| 264 |
Baxdrostat
|
|
695 KB
|
| 265 |
Cefepime-Tazobactam WCK 4282 vs. Meropenem
|
|
658 KB
|
| 266 |
Bempedoic Acid 180mg + Ezetimibe 10mg film coated tablets
|
|
337 KB
|
| 267 |
RO7200220
|
|
812 KB
|
| 268 |
Metformin Hydrochloride IP (SR) + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Linagliptin
|
|
326 KB
|
| 269 |
Dapagliflozin propanediol Monohydrate eq. to Dapagliflozin 10mg + Telmisartan 80mg film coated tablets
|
|
275 KB
|
| 270 |
Efruxifermindec
|
|
703 KB
|
| 271 |
ianalumabdec
|
|
658 KB
|
| 272 |
Tedizolid Phosphate 200mg Tablet
|
|
1090 KB
|
| 273 |
Desidustat Tablets 25mg, 50mg, 100mgCT/SND/27/2023
|
|
1240 KB
|
| 274 |
Cetuximab 100 mg/20 ml
|
|
807 KB
|
| 275 |
SAR443765
|
|
515 KB
|
| 276 |
Tislelizumab
|
|
653 KB
|
| 277 |
Ustekinumab Solution for Injection
|
|
1014 KB
|
| 278 |
Olezarsen (ISIS 678354)
|
|
682 KB
|
| 279 |
Zetomipzomib (KZR-616)
|
|
801 KB
|
| 280 |
Tropicamide 0.2mg + Phenylephrine Hydrochloride IP 3.1mg + Lidocaine Hydrochloride IP 10mg per ml Injection (Phase IV)
|
|
296 KB
|
| 281 |
Tenalisib 400mg Tablet
|
|
938 KB
|
| 282 |
Sitagliptin Phosphate IP 100mg + Lobeglitazone Sulfate 0.5mg film coated tablet
|
|
306 KB
|
| 283 |
Glimepiride IP + Linagliptin + Metformin HCL (As ER) IP (1mg + 2.5mg + 1000mg & 2mg + 2.5mg + 1000mg) film coated bilayered tablet
|
|
325 KB
|
| 284 |
Pregabalin IP 75mg + Duloxetine hydrochloride IP eq. to Duloxetine 30mg + Mecobalamin IP 1500mcg hard gelatin capsule
|
|
333 KB
|
| 285 |
Suplatast Tosilate 100mg Capsule
|
|
1290 KB
|
| 286 |
Tofacitinib Lotion 2%w/vCT/SND/26/2023
|
|
1528 KB
|
| 287 |
Povidone Iodine throat spray 0.45% w/vCT/SND/24/2023
|
|
14176 KB
|
| 288 |
Typhoid Vi Conjugate Vaccine I.P.
|
|
421 KB
|
| 289 |
POZELIMAB AND CEMDISIRAN23
|
|
665 KB
|
| 290 |
CRN04894
|
|
660 KB
|
| 291 |
20-valent Pneumococcal Conjugate vaccine
|
|
669 KB
|
| 292 |
LY3502970 Compared with Placebo
|
|
674 KB
|
| 293 |
Serpin PCInven
|
|
652 KB
|
| 294 |
TIN816
|
|
654 KB
|
| 295 |
Tezepelumab
|
|
677 KB
|
| 296 |
LY3502970l
|
|
670 KB
|
| 297 |
PEGylated Factor VIII(BAX 855)
|
|
673 KB
|
| 298 |
JDQ443
|
|
658 KB
|
| 299 |
BLU-5937IQVIA
|
|
666 KB
|
| 300 |
ESK-001
|
|
680 KB
|
| 301 |
LY3871801
|
|
659 KB
|
| 302 |
Efruxifermin
|
|
673 KB
|
| 303 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin 10mg + Lobeglitazone Sulfate 0.5mg film coated tablets (Phase III)
|
|
270 KB
|
| 304 |
Glimepiride IP + Metformin Hydrochloride IP (As sustained release) + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (1mg + 1000mg + 100mg & 2mg + 1000mg + 10mg) film coated bilayer tablets (Phase III)
|
|
312 KB
|
| 305 |
Combined tetanus toxoid, reduced diphtheria toxoid, reduced recombinant pertussis vaccine. (Tdapgen)
|
|
274 KB
|
| 306 |
Pacritinib
|
|
615 KB
|
| 307 |
Parenteral TK-112690
|
|
659 KB
|
| 308 |
Empagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (25mg + 100mg & 10mg + 100mg) film coated tablet (Phase III)
|
|
336 KB
|
| 309 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Empagliflozin (100mg + 25mg & 100mg + 10mg) film coated tablets (Phase III)
|
|
345 KB
|
| 310 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Empagliflozin (100mg + 25mg & 100mg + 10mg) film coated tablets (Phase III)
|
|
345 KB
|
| 311 |
Montelukast Sodium IP 10mg + Fexofenadine hydrochloride IP 180mg Uncoated bilayered tablet (Phase III)
|
|
319 KB
|
| 312 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin 10mg + Metoprolol Succinate IP eq. to Metoprolol TartrateExtended Release50mg film coated bilayered tablet
|
|
250 KB
|
| 313 |
Bilastine IP 3.3mg + Phenylephrine Hydrochloride IP 5mg + Dextromethorphan Hydrobromide IP 10mg syrup (Phase III)
|
|
353 KB
|
| 314 |
Oral NRC-2694-A
|
|
654 KB
|
| 315 |
LY3502970lily
|
|
678 KB
|
| 316 |
BEMNIFOSBUVIR (BEM) AND RUZASVIR (RZR)
|
|
654 KB
|
| 317 |
LY3437943eli
|
|
690 KB
|
| 318 |
PF-06823859
|
|
657 KB
|
| 319 |
NAPTUMOMAB ESTAFENATOX
|
|
512 KB
|
| 320 |
MK-7684 with Pembrolizumab
|
|
661 KB
|
| 321 |
TP-102
|
|
656 KB
|
| 322 |
IcoSema and daily insulin glargine 100 units/mL
|
|
678 KB
|
| 323 |
POZELIMAB AND CEMDISIRAN
|
|
665 KB
|
| 324 |
RIFAXIMIN SOLUBLE SOLID DISPERSION (SSD)
|
|
704 KB
|
| 325 |
Lumateperone
|
|
670 KB
|
| 326 |
Povidone Iodine Nasal Solution 0.5% w/vCT/SND/21/2023
|
|
1279 KB
|
| 327 |
ASTEGOLIMAB
|
|
697 KB
|
| 328 |
Mavacamten
|
|
663 KB
|
| 329 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg + Pioglitazone Hydrochloride IP 15mg film coated tablets (Phase III)
|
|
282 KB
|
| 330 |
Benralizumab 100mg
|
|
677 KB
|
| 331 |
Insulin Injection IP 100 IU/mL
|
|
578 KB
|
| 332 |
Vonoprazan Fumarate 20mg tablet
|
|
1994 KB
|
| 333 |
Dydrogesterone Modified Release Tablet 30mgCT-SND/22/2023
|
|
1487 KB
|
| 334 |
Glimepiride IP + Metformin Hydrochloride IP (as extended release) + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (1mg + 1000mg + 100mg & 2mg + 1000mg + 100mg) tablets (Phase III)
|
|
308 KB
|
| 335 |
Polmacoxib 2mg + Paracetamol IP 325 mg (Phase III)
|
|
299 KB
|
| 336 |
Denosumabcura
|
|
697 KB
|
| 337 |
Divozilimab
|
|
558 KB
|
| 338 |
LY3437943
|
|
672 KB
|
| 339 |
SerpinPC
|
|
641 KB
|
| 340 |
Dengue Tetravalent Vaccine (Live, Attenuated)
|
|
298 KB
|
| 341 |
Pegfilgrastim
|
|
885 KB
|
| 342 |
Insulin Lispro Ultrarapid(UR) Injection
|
|
669 KB
|
| 343 |
Atacicept
|
|
683 KB
|
| 344 |
Lumateperone Tosylate 42mg capsule
|
|
1137 KB
|
| 345 |
Milvexian, an Oral Factor XIa Inhibitor
|
|
739 KB
|
| 346 |
Metformin Hydrochloride IP (as ER) + Glimepiride IP + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (1000mg + 1mg + 100mg & 1000mg + 2mg + 100mg) film coated bilayered tablets (Phase III)
|
|
350 KB
|
| 347 |
Omalizumab
|
|
847 KB
|
| 348 |
Benralizumab
|
|
648 KB
|
| 349 |
Crovalimab
|
|
641 KB
|
| 350 |
Denosumab Injection
|
|
820 KB
|
| 351 |
Insulin Glargine Injection
|
|
578 KB
|
| 352 |
Denosumabrdna
|
|
733 KB
|
| 353 |
PB016 and Entyvio
|
|
723 KB
|
| 354 |
Tadalafil IP 5mg (as film coated tablet) + Tamsulosin Hydrochloride IP 0.4mg (Prolonged release tablet) hard gelatin capsules (Phase IV)
|
|
305 KB
|
| 355 |
Fexofenadine Hydrochloride IP 180mg + Montelukast Sodium IP eq. to Montelukast 10mg tablets (Phase III)
|
|
316 KB
|
| 356 |
Varespladib
|
|
648 KB
|
| 357 |
Tozorakimab (MEDI3506)
|
|
672 KB
|
| 358 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin 10mg + Metoprolol Succinate IP eq. to Metoprolol Tartrate (as extended release) 50mg film coated bilayered tablet (Phase III)
|
|
583 KB
|
| 359 |
nebulized PC945
|
|
654 KB
|
| 360 |
FXIa inhibitor asundexian (BAY 2433334)
|
|
547 KB
|
| 361 |
RSVPreF3
|
|
615 KB
|
| 362 |
Bilastine 40mg + Montelukast Sodium IP eq. to Montelukast 10mg tablets (Phase III)
|
|
291 KB
|
| 363 |
Quadrivalent Human Papillomavirus (Serotypes 6, 11, 16 & 18) Vaccine
|
|
441 KB
|
| 364 |
Trinbelimab Injection
|
|
734 KB
|
| 365 |
Denosumab
|
|
643 KB
|
| 366 |
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (14 Valent)
|
|
341 KB
|
| 367 |
BI1015550
|
|
643 KB
|
| 368 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Bisoprolol Fumarate IP (10mg + 5mg & 10mg +10mg) tablet (Phase III)
|
|
508 KB
|
| 369 |
Bempedoic Acid + Rosuvastatin Calcium IP eq. to Rosuvastatin (180mg + 5mg, 180mg + 10mg & 180mg + 20mg) tablets (Phase III)
|
|
587 KB
|
| 370 |
Dapagliflozin propanediol Monohydrate eq. to Dapagliflozin + Linagliptin + Metformin Hydrochloride IP (as sustained release) tablets (Phase III)
|
|
406 KB
|
| 371 |
WD1905 Tablets with SINEMET
|
|
637 KB
|
| 372 |
Indacaterol (as acetate) eq. to Indacaterol + Glycopyrrolate IP eq. to Glycopyrronium + Mometasone Furoate IP powder for inhalation (Phase IV)
|
|
348 KB
|
| 373 |
LY3502970
|
|
681 KB
|
| 374 |
HT-6184
|
|
636 KB
|
| 375 |
Tenecteplase
|
|
732 KB
|
| 376 |
Budesonide IP + Formoterol Fumarate IP + Glycopyrronium Ph. Eur inhalation powder (Phase IV
|
|
435 KB
|
| 377 |
Bilastine + Dextromethorphan Hydrobromide + Phenylephrine Hydrochloride syrup (Phase III)
|
|
414 KB
|
| 378 |
Febuxostat Extended Release Tablet 40mg/80mgCT/SND/15/2023
|
|
1370 KB
|
| 379 |
RLS Protein Subunit Vaccine against SARS CoV 2 Virus
|
|
612 KB
|
| 380 |
Afliberceptz
|
|
624 KB
|
| 381 |
Tofacitinib film forming lotion 2% w/wCT/SND/19/2023
|
|
1334 KB
|
| 382 |
Pilocarpine Hydrochloride Solution USP 1.25% w/vCT/SND/18/2023
|
|
1220 KB
|
| 383 |
PZN-128 powder for solution
|
|
480 KB
|
| 384 |
IPV vaccine
|
|
410 KB
|
| 385 |
Pregabalin Gel 8% w/wCT/SND/17/2023
|
|
1358 KB
|
| 386 |
Ketamine Solution 50mg/mlCT/SND/16/2023
|
|
1461 KB
|
| 387 |
Gedatolisib
|
|
657 KB
|
| 388 |
Milvexian, an Oral Factor XIa
|
|
684 KB
|
| 389 |
NM8074
|
|
692 KB
|
| 390 |
CC-92480 (BMS-986348)
|
|
663 KB
|
| 391 |
ExPEC9V
|
|
668 KB
|
| 392 |
Metformin Hydrochloride IP (As Extended release form) + Pioglitazone Hydrochloride IP eq. to Pioglitazone + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin tablets (Phase IV)
|
|
314 KB
|
| 393 |
Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin + Metformin Hydrochloride IP (SR) + Pioglitazone Hydrochloride IP film coated bilayered tablets (Phase IV
|
|
329 KB
|
| 394 |
Mirabegron (as extended release form) + Silodosin tablets (Phase III)
|
|
313 KB
|
| 395 |
AZD2693
|
|
405 KB
|
| 396 |
Tegoprazan
|
|
535 KB
|
| 397 |
ianalumab (VAY736)g
|
|
636 KB
|
| 398 |
HRF-10071 and Lamivudine
|
|
1753 KB
|
| 399 |
Levormeloxifene
|
|
2039 KB
|
| 400 |
Indacaterol Acetate eq. to Indacaterol IH+ Glycopyrronium Bromide eq. to Glycopyrronium Ph Eur + Mometasone Furoate eq. to Mometasone Furoate IP inhalation powder (Phase IV)
|
|
313 KB
|
| 401 |
LtdLNP3693
|
|
2170 KB
|
| 402 |
GIREDESTRANT
|
|
663 KB
|
| 403 |
BI 685509
|
|
645 KB
|
| 404 |
cagrilintide 2.4 mg s.c.
|
|
695 KB
|
| 405 |
Varicella Vaccine
|
|
391 KB
|
| 406 |
Diltiazem Hydrochloride 2% Gel
|
|
385 KB
|
| 407 |
Dydrogesterone Sustained Release Tablet 20mgCT/SND/13/2023
|
|
17478 KB
|
| 408 |
Ozanimod
|
|
404 KB
|
| 409 |
Dydrogesterone Sustained Release Tablet 20mgCT/SND/10/2023
|
|
1513 KB
|
| 410 |
Dydrogesterone Extended Release Tablet 30mg
|
|
1106 KB
|
| 411 |
Dydrogesterone Modified Release Tablet 20mg
|
|
1484 KB
|
| 412 |
TeriparatideI
|
|
772 KB
|
| 413 |
Pegfilgrastim Injection
|
|
660 KB
|
| 414 |
Pertuzumab And Trastuzumab
|
|
653 KB
|
| 415 |
Diperoxochloric acid topical solution 0.29mg/mlCT/SND/12/2023
|
|
1751 KB
|
| 416 |
Imeglimin 500mg and 1000mg tablets
|
|
2234 KB
|
| 417 |
MK-7684A (Vibostolimab with Pembrolizumab)
|
|
640 KB
|
| 418 |
BI 1015550
|
|
393 KB
|
| 419 |
TAR-200
|
|
648 KB
|
| 420 |
AUR107,
|
|
3145 KB
|
| 421 |
Insulin Aspart Mix 70/30 Injection
|
|
749 KB
|
| 422 |
ADL-018 150 mg and 300 mg
|
|
454 KB
|
| 423 |
Anti-COVID-19 AKS-452
|
|
644 KB
|
| 424 |
Mino-Lok Therapy (MLT)
|
|
668 KB
|
| 425 |
VTX958
|
|
642 KB
|
| 426 |
ianalumab (VAY736)
|
|
640 KB
|
| 427 |
Montelukast Sodium IP + Bilastine orodispersible tablets (Phase IV)
|
|
322 KB
|
| 428 |
Gabapentin IP + Nortriptyline HCl IP eq. to Nortriptyline film coated tablets (Phase IV)
|
|
271 KB
|
| 429 |
finerenone plus empagliflozin
|
|
655 KB
|
| 430 |
BevacizumabRLS
|
|
651 KB
|
| 431 |
Vedolizumab injection
|
|
696 KB
|
| 432 |
Asciminib
|
|
641 KB
|
| 433 |
BLU-5937
|
|
405 KB
|
| 434 |
PertuzumabA
|
|
915 KB
|
| 435 |
Sovateltide injection 30μg
|
|
2837 KB
|
| 436 |
Dydrogesterone Sustained Release Tablet 30mgCT/SND/09/2023
|
|
1223 KB
|
| 437 |
CKJX839D12302inclisiran
|
|
689 KB
|
| 438 |
Darbepoetin alfa
|
|
763 KB
|
| 439 |
Idursulfase
|
|
672 KB
|
| 440 |
Japanese Encephalitis Vaccine
|
|
139 KB
|
| 441 |
Tofacitinib Gel 2% w/w
|
|
438 KB
|
| 442 |
(+)-Alpha- Dihydrotetrabenazine ({+})-α-DHTBZ) Powder
|
|
2205 KB
|
| 443 |
Glycopyrronium (As Glycopyrrolate IP) + Budesonide IP + Formoterol Fumarate (As Formoterol Fumarate Dihydrate IP) powder for inhalation (in capsule) (Phase IV)
|
|
325 KB
|
| 444 |
Nor-Ursodeoxycholic Acid 1500mg
|
|
2575 KB
|
| 445 |
SAR408701 versus docetaxel
|
|
507 KB
|
| 446 |
Auxora
|
|
639 KB
|
| 447 |
Ustekinumab
|
|
681 KB
|
| 448 |
Bemnifosbuvir
|
|
672 KB
|
| 449 |
Amoxycillin Trihydrate IP eq. to Amoxycillin + Potassium Clavulanate diluted IP eq. to Clavulanic Acid of the reconstituted suspension (Phase IV)
|
|
362 KB
|
| 450 |
ABX464
|
|
676 KB
|
| 451 |
ABX464 once daily
|
|
667 KB
|
| 452 |
Fluconazole (MARIO)
|
|
651 KB
|
| 453 |
ABX464 25 mg or 50 mg
|
|
727 KB
|
| 454 |
Guselkumab and Golimumab in Participants
|
|
644 KB
|
| 455 |
Guselkumab and Golimumab
|
|
649 KB
|
| 456 |
Aztreonam- Avibactam ± Metronidazole
|
|
638 KB
|
| 457 |
ziltivekimab
|
|
697 KB
|
| 458 |
ARV-471 (PF-07850327)
|
|
661 KB
|
| 459 |
Daratumumab SC and Lenalidomide (Tec-DR)
|
|
645 KB
|
| 460 |
Tildrakizumab
|
|
508 KB
|
| 461 |
Adalimumab Injection
|
|
731 KB
|
| 462 |
Oral Ozanimod
|
|
662 KB
|
| 463 |
Hexavalent DtwP-HepB-IPV-Heb Liq.Hexa vaccine
|
|
127 KB
|
| 464 |
Linagliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin tablets (Phase III)
|
|
345 KB
|
| 465 |
Glycopyrrolate IP + Budesonide IP + Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumarate per actuation delivers (ex-actuator) inhalation aerosol (Phase IV)
|
|
311 KB
|
| 466 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Pioglitazone Hydrochloride IP Eq. to Pioglitazone tablets (Phase III)
|
|
289 KB
|
| 467 |
Bupropion Hydrochloride IP (as extended release) + Dextromethorphan Hydrobromide IP tablets (Phase III)
|
|
365 KB
|
| 468 |
Guselkmab
|
|
650 KB
|
| 469 |
Guselkumab
|
|
650 KB
|
| 470 |
FluticasonePropionate HFA Pressurized Metered Dose Inhaler 110mcg ex-actuator dose (125rncg ex-valve dose)
|
|
2510 KB
|
| 471 |
Fluticasone Propionate HFA ,Pressurized Metered Dose Inhaler 110mcg ex-actuator dose (125rncg ex-valve dose)
|
|
1256 KB
|
| 472 |
Vonoprazan 20 Mg. Tablets/ Pantoprazole 40 Mg
|
|
125 KB
|
| 473 |
Vonoprazan 20 Mg Tablets/ Pantoprazole 40 Mg
|
|
2421 KB
|
| 474 |
Faricimab (RO686746
|
|
656 KB
|
| 475 |
Datopotamab Deruxtecan (Dato-DXd)
|
|
657 KB
|
| 476 |
Trastuzumab
|
|
752 KB
|
| 477 |
Ozanimod
|
|
662 KB
|
| 478 |
AUR108
|
|
2378 KB
|
| 479 |
filgotinib
|
|
655 KB
|
| 480 |
Ixekizumab
|
|
657 KB
|
| 481 |
Lumateperone
|
|
677 KB
|
| 482 |
Topical 1% AKP-11
|
|
2339 KB
|
| 483 |
AUR107
|
|
2418 KB
|
| 484 |
Lumateperone as Adjunctive Therapy
|
|
677 KB
|
| 485 |
Agalsidase alfa
|
|
567 KB
|
| 486 |
Imlunestrant
|
|
674 KB
|
| 487 |
Basimglurant
|
|
667 KB
|
| 488 |
Ranibizumab r-dna
|
|
693 KB
|
| 489 |
Pertuzumabf
|
|
832 KB
|
| 490 |
Pegfilgrastimn
|
|
699 KB
|
| 491 |
Imeglimin Hydrochloride sustend release tablets 1000 mg
|
|
2277 KB
|
| 492 |
ianalumab (VAY736)
|
|
639 KB
|
| 493 |
fitusiran prophylaxis
|
|
498 KB
|
| 494 |
Coagulation Factor VIII (Recombinant) rFVIII
|
|
840 KB
|
| 495 |
Ocrelizumab
|
|
675 KB
|
| 496 |
ARO-APOC3
|
|
771 KB
|
| 497 |
Aflibercept
|
|
1115 KB
|
| 498 |
xevinapant
|
|
645 KB
|
| 499 |
cagrilintide s.c. 2.4 mg
|
|
675 KB
|
| 500 |
Sodium Zirconium Cyclosilicatec
|
|
378 KB
|
| 501 |
JNJ-63723283
|
|
657 KB
|
| 502 |
Teclistamab
|
|
653 KB
|
| 503 |
Tozorakimab
|
|
660 KB
|
| 504 |
Dydrogesterone Extended Release Tablet 20 mg/30mgCT/SND/01/2023
|
|
1084 KB
|
| 505 |
Dydrogesterone Extended Release Tablet 20 mgM
|
|
358 KB
|
| 506 |
EPX-100
|
|
749 KB
|
| 507 |
Tofacitinib Gel 2% w/wCT/SND/07/2023
|
|
1268 KB
|
| 508 |
Glimepiride IP + Linagliptin film coated tablets (Phase III)
|
|
354 KB
|
| 509 |
Glimepiride IP + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin tablets (Phase III)
|
|
367 KB
|
| 510 |
Pioglitazone Hydrochloride IP Eq. to Pioglitazone Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated tablets (Phase III)
|
|
327 KB
|
| 511 |
HRF-10071 tablet 120 mg and Metformin 500mg IR Tablet
|
|
2048 KB
|
| 512 |
AUR106
|
|
2112 KB
|
| 513 |
Rosuvastatin Calcium IP eq. to Rosuvastatin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin tablets (Phase III)
|
|
395 KB
|
| 514 |
Chlorthalidone IP + Cilnidipine IP + Bisoprolol Fumarate IP film coated tablets
|
|
298 KB
|
| 515 |
Vildagliptin + Dapagliflozin + Metformin Hydrochloride IP tablets (Phase III)
|
|
304 KB
|
| 516 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Pioglitazone HCl IP eq. to Pioglitazone film coated tablets (Phase III)
|
|
308 KB
|
| 517 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Linagliptin film coated tablets
|
|
329 KB
|
| 518 |
Dydrogesterone Extended Release Tablet 20 mg
|
|
1221 KB
|
| 519 |
Dydrogesterone Extended Release Tablet 20 mg
|
|
411 KB
|
| 520 |
FS118
|
|
699 KB
|
| 521 |
HBI-8000 Combined with Nivolumab
|
|
661 KB
|
| 522 |
17β-Hydroxysteroid Dehydrogenase type 13
|
|
654 KB
|
| 523 |
Tirzepatide
|
|
664 KB
|
| 524 |
LY3209590
|
|
644 KB
|
| 525 |
Ranibizumab
|
|
715 KB
|
| 526 |
Faricimab (RO6867461)
|
|
640 KB
|
| 527 |
JDQ443 versus docetaxel
|
|
651 KB
|
| 528 |
Pertuzumab
|
|
780 KB
|
| 529 |
Dydrogesterone Sustained Release Tablet 30 mg
|
|
1665 KB
|
| 530 |
Ianalumab CT/22/000006
|
|
657 KB
|
| 531 |
MORF-057
|
|
667 KB
|
| 532 |
Vilanterol Trifenatate eq. to Vilanterol + Glycopyrrolate IP eq. to Glycopyrronium metered dose inhalation (Phase III)
|
|
380 KB
|
| 533 |
ianalumab
|
|
657 KB
|
| 534 |
Elagolix Tablets 150 mg & 200mg
|
|
2413 KB
|
| 535 |
POZELIMAB AND CEMDISIRAN
|
|
677 KB
|
| 536 |
Elagolix Tablets ,150 mg & 200mg
|
|
2413 KB
|
| 537 |
Sodium Zirconium Cyclosilicate
|
|
671 KB
|
| 538 |
Bepirovirsen
|
|
680 KB
|
| 539 |
Bepirovirsen in HBeAg-negative
|
|
682 KB
|
| 540 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Metoprolol Succinate IP eq. to Metoprolol Tartrate (As sustained release) film coated bilayered tablets (Phase III)
|
|
349 KB
|
| 541 |
Liquid Nasal Spray (Nitric oxide) (100 ppm)
|
|
351 KB
|
| 542 |
Fosnetupitant, 235 mg and Palonosetron 0.25mg
|
|
2472 KB
|
| 543 |
Fosnetupitant 235 mg and Palonosetron 0.25mg
|
|
2476 KB
|
| 544 |
Vildagliptin IP + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated tablets (Phase III)
|
|
351 KB
|
| 545 |
Imeglimi.n Hydrochloride sustend release tablets 1000 mg
|
|
2277 KB
|
| 546 |
Recombinant Rabies G protein Vaccine
|
|
94 KB
|
| 547 |
VTX002
|
|
661 KB
|
| 548 |
Hydrochloride, 500 tablets
|
|
2545 KB
|
| 549 |
sImeglimin Hydrochloride 1000 tablets
|
|
2845 KB
|
| 550 |
sImeglimin Hydrochloride 500 tablets
|
|
2545 KB
|
| 551 |
Imeglimin. Hydrochloride 1000 tablets
|
|
2845 KB
|
| 552 |
(Research Park)LNP7457
|
|
2397 KB
|
| 553 |
NV-CoV-2 Oral Syrup Oral Gummy(Chewable gel)
|
|
2202 KB
|
| 554 |
Bisoprolol Fumarate IP 5mg + Cilnidipine IP film coated tablets (Phase III)
|
|
346 KB
|
| 555 |
Prolectin-I Injection
|
|
1915 KB
|
| 556 |
Vonoprazan, Tablets 10mg/20mg
|
|
2768 KB
|
| 557 |
Vonoprazan Tablets 10mg/20mg
|
|
2786 KB
|
| 558 |
Tegoprazan .50 mg tablets
|
|
2016 KB
|
| 559 |
Polmacoxib Capsules 2 mg
|
|
2399 KB
|
| 560 |
Polmacoxib. Capsules 2 mg
|
|
2399 KB
|
| 561 |
AZD9977 and Dapagliflozin
|
|
669 KB
|
| 562 |
Lorlatinib
|
|
658 KB
|
| 563 |
Glimepiride IP + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP film coated tablets (Phase III)
|
|
440 KB
|
| 564 |
Norditropin®
|
|
507 KB
|
| 565 |
20-valent Pneumococcal Conjugate (20vPnC) Vaccine
|
|
556 KB
|
| 566 |
Marstacimab Prophylaxi
|
|
654 KB
|
| 567 |
Macitentan 75 mg
|
|
516 KB
|
| 568 |
Trastuzumab Emtasine
|
|
698 KB
|
| 569 |
Metformin Hydrochloride IP (as extended release) + Dapagliflozin + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin film coated bilayered tablets (Phase III)
|
|
287 KB
|
| 570 |
Cannabidol Oral. Solution 150 mg/ml
|
|
2629 KB
|
| 571 |
Linagliptin + Dapagliflozin tablets (Phase III)
|
|
275 KB
|
| 572 |
Vilanterol trifenatate eq. to Vilanterol + Glycopyrrolate IP eq. to Glycopyrronium + Flucticasone Furoate Ph. Eur metered dose inhalation (Phase III)
|
|
318 KB
|
| 573 |
Glimepiride IP + Metformin Hydrochloride IP + Sitagliptin Phosphate Monohydrate IP film coated tablets (Phase III)
|
|
324 KB
|
| 574 |
Cannabidol Oral Solution 150 mg/ml
|
|
2629 KB
|
| 575 |
Tegoprazan 50 mg tablets
|
|
2016 KB
|
| 576 |
Tildrakizumab23jan
|
|
664 KB
|
| 577 |
ianalumab
|
|
657 KB
|
| 578 |
Ibrutinib
|
|
514 KB
|
| 579 |
Pioglitazone Hydrochloride IP eq. to Pioglitazone + Sitagliptin Phosphate Monohydrochloride IP eq. to Sitagliptin tablet (Phase III)
|
|
307 KB
|
| 580 |
FB2001
|
|
528 KB
|
| 581 |
Romosozumab
|
|
842 KB
|
| 582 |
NNC 0365-3769 (Mim8) prophylaxis
|
|
514 KB
|
| 583 |
LYT-100
|
|
681 KB
|
| 584 |
S-217622
|
|
588 KB
|
| 585 |
Tildrakizumab
|
|
663 KB
|
| 586 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Glimperide IP + Metformin Hydrochloride IP (as extended release) film coated tablets
|
|
376 KB
|
| 587 |
Ursodiol Injection 625 mg/25ml (25mg/ml
|
|
404 KB
|
| 588 |
Metformin Hydrochloride IP (As extended release) + Glimepiride IP + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated bilayered tablet
|
|
334 KB
|
| 589 |
Gliclazide IP (As sustained release) + Dapagliflozin film coated bilayered tablets (Phase III)
|
|
307 KB
|
| 590 |
TEV-45779
|
|
770 KB
|
| 591 |
Prolectin M
|
|
2190 KB
|
| 592 |
Trelagliptin tablets 25mg/50mg/100mg
|
|
2552 KB
|
| 593 |
IVIEW-1201
|
|
405 KB
|
| 594 |
Glycopyrroinum Bromide Ph. Eur + Fluticasone Furoate + Vilanterol Trifenatate inhalation powder
|
|
293 KB
|
| 595 |
Tildrakizumab Injection
|
|
720 KB
|
| 596 |
Recombinant human FSH
|
|
699 KB
|
| 597 |
STN1010904
|
|
401 KB
|
| 598 |
Human Albumin (r-DNA origin)
|
|
705 KB
|
| 599 |
decitabine-tetrahydrouridine
|
|
345 KB
|
| 600 |
Pimavenserin Capsules 34 mg
|
|
2383 KB
|
| 601 |
Lasmiditan tablets 50 mg / 100 mg
|
|
2304 KB
|
| 602 |
Imeglimin Hydrochloride Sustained Relase Tablet 1000 mg
|
|
482 KB
|
| 603 |
Ranibizumab Solution for Injection, 10 mg/mL vial
|
|
696 KB
|
| 604 |
Glycopyrroinum Bromide Ph. Eur + Vilanterol Trifenatate inhalation powder
|
|
328 KB
|
| 605 |
Dapagliflozin Propanediol monohydrate + Linagliptin film coated tablets (Phase III)
|
|
4371 KB
|
| 606 |
Mesenchymal Stem Cell
|
|
663 KB
|
| 607 |
Paracetamol Injection 1000 mg/4ml iv use
|
|
501 KB
|
| 608 |
Luspatercept powder for solution for injection: 25 mg and 75 mg
|
|
796 KB
|
| 609 |
Docetaxel
|
|
788 KB
|
| 610 |
101-PGC-005â¦20mg
|
|
2347 KB
|
| 611 |
101-PGC-005â¦20mg
|
|
2347 KB
|
| 612 |
Asunercept
|
|
791 KB
|
| 613 |
Metformin Hydrochloride IP + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated bilayered tablet (Phase III)
|
|
320 KB
|
| 614 |
LL-BMT1
|
|
701 KB
|
| 615 |
Recombinant Hepatits E
|
|
228 KB
|
| 616 |
QIV Vaccine
|
|
438 KB
|
| 617 |
BCD-201 (JSC BIOCAD) and Keytruda®
|
|
797 KB
|
| 618 |
HRF-10071 -120 mg
|
|
2200 KB
|
| 619 |
HRF-100071- 20 mg/40mg/ 100mg
|
|
2576 KB
|
| 620 |
NBTXR3
|
|
668 KB
|
| 621 |
SAR440340/REGN3500/itepekimabd
|
|
333 KB
|
| 622 |
Pregabalin IP (as prolonged release) + Etoricoxib IP film coated bilayered tablets (Phase IV)
|
|
348 KB
|
| 623 |
Hexavalent Vaccine
|
|
561 KB
|
| 624 |
Vildagliptin + Pioglitazone Hcl IP eq. Pioglitazone uncoated tablet (Phase III)
|
|
326 KB
|
| 625 |
Alcohol IP + Ketoprofen IP gel (Phase III)
|
|
271 KB
|
| 626 |
Metformin Hydrochloride IP + Glimepiride IP + Dapagliflozin Propanediol Monohydrate tablets (Phase III).
|
|
303 KB
|
| 627 |
Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin + Pioglitazone Hydrochloride IP equivalent to Pioglitazone film coated tablets (Phase III)
|
|
393 KB
|
| 628 |
BCD-217 (Nurulimab + Prolgolimab)
|
|
667 KB
|
| 629 |
Etifoxine HCl 50 mg
|
|
2623 KB
|
| 630 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Pioglitazone Hydrochloride IP eq. to Pioglitazone IP + Metformin Hydrochloride IP (as sustained release) IP tablets (Phase III)
|
|
286 KB
|
| 631 |
Liothyronine Sodium Tablets 5mcg & 20 mcg
|
|
2533 KB
|
| 632 |
Gliclazide IP (As sustained release) + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin film coated bilayered tablets (Phase III)
|
|
367 KB
|
| 633 |
Dulaglutide solution for injection 0.75mg and 1.5mg prefilled pen
|
|
712 KB
|
| 634 |
Linagliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin tablets (Phase III)
|
|
307 KB
|
| 635 |
mepolizumab 100 mg SC
|
|
688 KB
|
| 636 |
Ivermectin cutaneous solution 0.5%
|
|
665 KB
|
| 637 |
Durvalumab plus Olaparib
|
|
679 KB
|
| 638 |
cagrilintide s.c. 2.4 mg
|
|
588 KB
|
| 639 |
Diphtheria and Tetanus vaccine for Adults and Adolescents I.P (Td Vaccine)
|
|
91 KB
|
| 640 |
Pneumococcal Conjugate Vaccine (2+1 schedule)
|
|
141 KB
|
| 641 |
Montelukast IP + Fexofenadine Hydrochloride IP suspension (Phase III)
|
|
323 KB
|
| 642 |
Elagolix tablets 150 mg
|
|
2471 KB
|
| 643 |
Latanoprost IP + Netarsudil Mesylate eq. to Netarsudil + Benzalkonium Chloride IP (As preservative) per ml ophthalmic solution (Phase III)
|
|
287 KB
|
| 644 |
Thymosin Alpha 1 for injection 1.6mg
|
|
420 KB
|
| 645 |
Pioglitazone Hydrochloride IP eq. to Pioglitazone + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin tablets (Phase III)
|
|
410 KB
|
| 646 |
Brilaroxazine (RP5063)
|
|
671 KB
|
| 647 |
Aflibercept with Eylea
|
|
789 KB
|
| 648 |
AVT06 Compared with EU-Eylea
|
|
813 KB
|
| 649 |
C-TB, Tubercullin PPD RT23 SSI
|
|
1988 KB
|
| 650 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP + Glimepiride IP film coated tablet (Phase III).
|
|
325 KB
|
| 651 |
Itolizumab for Injection 100 mg/vial
|
|
574 KB
|
| 652 |
Liraglutide injection 6mg/ml
|
|
724 KB
|
| 653 |
Lyophilized mRNA Vaccine for Injection (COVID-19
|
|
234 KB
|
| 654 |
Solifenacin Succinate IP + Silodosin film coated bilayered tablets (Phase III)
|
|
279 KB
|
| 655 |
Desidustat 50 mg
|
|
2107 KB
|
| 656 |
Nivolumab
|
|
1158 KB
|
| 657 |
Proxalutamide (GT0918)
|
|
656 KB
|
| 658 |
Sitagliptin Phosphate Monohydrate eq. to Sitagliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Metformin Hydrochloride IP (As extended release) film coated bilayered tablet (Phase III),
|
|
334 KB
|
| 659 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP (As extended release form) tablets (Phase III),
|
|
284 KB
|
| 660 |
Vildagliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin tablet (Phase III)
|
|
242 KB
|
| 661 |
[+]-α-dihydrotetrabenazine [ -α- DHTB -5mg/7.5mg/10mg/15mg/22.5mg
|
|
2181 KB
|
| 662 |
Pantoprazole Sodium IP eq. to Pantoprazole (as gastro-resistant tablet) + Acotiamide Hydrochloride Hydrate (as 3 extended release tablets of each) hard gelatin capsules (Phase III)
|
|
308 KB
|
| 663 |
Pseudoephedrine Hydrochloride IP + Fexofenadine Hydrochloride IP extended release tablet (Phase IV
|
|
292 KB
|
| 664 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP (as extended release form) tablet (Phase III)
|
|
312 KB
|
| 665 |
Sibeprenlimab
|
|
670 KB
|
| 666 |
Bisoprolol Fumarate IP + Telmisartan IP film coated bilayered tablet (Phase III)
|
|
353 KB
|
| 667 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Glimepiride IP + Metformin Hydrochloride IP (As sustained release form) film coated bilayered tablet (Phase III)
|
|
318 KB
|
| 668 |
Lifitegrast Opthalamic Solution 5%
|
|
2753 KB
|
| 669 |
Pneumococcal Polysaccharide Conjugate Vaccine (adsorbed), I.P. (15 valent
|
|
429 KB
|
| 670 |
Datopotamab Deruxtecan (Dato-DXd)
|
|
481 KB
|
| 671 |
SAR440340/REGN3500/itepekimab
|
|
511 KB
|
| 672 |
Carboplatin and Paclitaxel
|
|
673 KB
|
| 673 |
Adenoviral-Vector Based Vaccine (VXA-CoV2-1.1-S) (Enteric Coated Tablet)
|
|
397 KB
|
| 674 |
Ticagrelor 180 mg Tablet
|
|
3675 KB
|
| 675 |
Live Attenuated Tetravalent Recombinant Dengue Vaccine
|
|
194 KB
|
| 676 |
Efonidipine Hydrochloride Ethanolate + Telmisartan IP film coated bilayered tablet (Phase IV)
|
|
306 KB
|
| 677 |
Silodosin + Mirabegron (SR) film coated bilayered tablets (Phase III)
|
|
296 KB
|
| 678 |
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (14
|
|
226 KB
|
| 679 |
Insulin Injection,Biphasic Isophane Ph.Eur 100IU/ml
|
|
851 KB
|
| 680 |
Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated tablets (Phase III)
|
|
307 KB
|
| 681 |
Metformin Hydrochloride IP (As extended release) + Glimepiride IP + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated bilayered tablet (Phase 3
|
|
300 KB
|
| 682 |
Metformin Hydrochloride IP eq. to Metformin (as extended release form) + Dapagliflozin + Sitagliptin Phosphate monohydrate IP eq. to Sitagliptin film coated tablets (Phase III)
|
|
297 KB
|
| 683 |
Triamcinolone Acetonide Cream 0.1% w/w
|
|
548 KB
|
| 684 |
Metformin Hydrochloride IP (as extended release) + Glimepiride IP + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated tablet (Phase III)
|
|
363 KB
|
| 685 |
Metformin Hydrochloride IP (Extended release) + Glimepiride IP 1mg + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin film coated bilayered tablet (Phase III)
|
|
314 KB
|
| 686 |
Tinofovir Pivafen Fumarate 50 mg
|
|
1982 KB
|
| 687 |
Metformin Hydrochloride IP (as sustained release) + Vildagliptin (as sustained release) + Dapagliflozin tablets (Phase III)
|
|
360 KB
|
| 688 |
Dapagliflozin + Pioglitazone Hydrochloride IP eq. to Pioglitazone film coated tablets (Phase III)
|
|
309 KB
|
| 689 |
HRF-10071tablets 120 mg and Rifampicin 600 mg capsules
|
|
2183 KB
|
| 690 |
HRF-10071tablets 120 mg and Pravastatin 40 mg
|
|
2028 KB
|
| 691 |
Selpercatinib
|
|
653 KB
|
| 692 |
Mino-Lok Therapy (MLT
|
|
649 KB
|
| 693 |
Finerenone 10 mg and 20 mg
|
|
2588 KB
|
| 694 |
SRP-4045 and SRP-4053
|
|
659 KB
|
| 695 |
AB001 400mg Tablets
|
|
2052 KB
|
| 696 |
AZD1222 Vaccine
|
|
674 KB
|
| 697 |
ZY19489
|
|
2030 KB
|
| 698 |
PNB001
|
|
2240 KB
|
| 699 |
Eteplirsen
|
|
667 KB
|
| 700 |
Clotrimazole Vaginal Film 50 mg
|
|
437 KB
|
| 701 |
Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (ER) + Telmisartan IP + Amlodipine Besilate IP eq. to Amlodipine Film Coated Bilayered tablet (Phase III)
|
|
414 KB
|
| 702 |
Thymosin Alpha 1 for injection 1.6 mg
|
|
411 KB
|
| 703 |
LNP023
|
|
659 KB
|
| 704 |
LNP023gc
|
|
659 KB
|
| 705 |
Dupilumabr
|
|
792 KB
|
| 706 |
Ramatroban tablets 75 mg
|
|
1855 KB
|
| 707 |
Sovateltide
|
|
2118 KB
|
| 708 |
Vildagliptin (as sustained release form) + Metformin Hydrochloride As sustained release formIP uncoated bilayered tablets (Phase III
|
|
182 KB
|
| 709 |
Pantoprazole Dual Release Gastro-Resistant Tablet 80 mg
|
|
372 KB
|
| 710 |
Inhaled Itracoanzole Dry Powder for inhalation 10 mg capsule (PUR 1900)
|
|
471 KB
|
| 711 |
Glycopyrrolate IP + Formoterol Fumarate dehydrate IP eq. to Formoterol Fumarate + Budesonide IP Per actuation deliver (Phase IV)
|
|
184 KB
|
| 712 |
ES16001
|
|
645 KB
|
| 713 |
inclisiran
|
|
645 KB
|
| 714 |
Telmisartan IP + Bisoprolol Fumarate IP tablets (Phase III)
|
|
256 KB
|
| 715 |
Azelastine Hydrohloride 1 mg/ml Nasal Spray
|
|
423 KB
|
| 716 |
101-PGC-005
|
|
2107 KB
|
| 717 |
Guselkumab
|
|
788 KB
|
| 718 |
HRF-10071, Darunavir and Ritonavir
|
|
2004 KB
|
| 719 |
remibrutinib versus teriflunomide
|
|
661 KB
|
| 720 |
NRC-1111
|
|
2198 KB
|
| 721 |
Fosfomycin Trometamol Powder 3 gm
|
|
477 KB
|
| 722 |
Pneumococcal Polysaccharide Conjugate Vaccine I.P. (PCV13-TT
|
|
562 KB
|
| 723 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Linagliptin film coated tablet (Phase III)
|
|
283 KB
|
| 724 |
Mirabegron (ER) + Solifenacin Succinate IP film coated bilayered tablet (Phase IV
|
|
186 KB
|
| 725 |
Teriparatide 20microgram/80 micro litre solution for injection in prefilled pen
|
|
828 KB
|
| 726 |
Vildagliptin IP (as sustained release)Pioglitazone Hydrochloride IP eq. to Pioglitazone tablets (Phase III)
|
|
229 KB
|
| 727 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP film coated tabletPhase III)
|
|
195 KB
|
| 728 |
Vericiguat therapy
|
|
2443 KB
|
| 729 |
Dapagliflozin IP +Metformin Hydrochloride IP (as sustained release) + Sitagliptin Phosphate Monohydrate IP bilayered tablet (Phase III)
|
|
192 KB
|
| 730 |
Rabies Vaccine, Human I.P. [Purified Inactivated Vero Cell Rabies vaccine â Lyophilized
|
|
484 KB
|
| 731 |
Metformin Hydrochloride IP (SR) + Pioglitazone Hydrochloride IP + Sitagliptin Phosphate IP eq. to Sitagliptin film coated bilayered tablet (Phase III)
|
|
206 KB
|
| 732 |
Dupilumabn
|
|
691 KB
|
| 733 |
Paclitaxel-Carboplatin-Oregovomab)
|
|
673 KB
|
| 734 |
Ondansetron Extended Relese Injectable Supension 100mg/ml
|
|
400 KB
|
| 735 |
Typhoid Conjugate Vaccine (Bivalent)
|
|
235 KB
|
| 736 |
Vildagliptin + Pioglitazone Hydrochloride IP eq. to Pioglitazone uncoated tabletsPhase III)
|
|
211 KB
|
| 737 |
Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as extended release) + Amlodipine Besilate IP eq. to Amlodipine + Chlorthalidone IP film coated bilayered tablets (Phase III)
|
|
206 KB
|
| 738 |
remibrutinib versus teriflunomidegc
|
|
654 KB
|
| 739 |
Trelagliptin
|
|
2481 KB
|
| 740 |
HRF-10071 and Dolutegravir
|
|
2256 KB
|
| 741 |
Durvalumabgct
|
|
668 KB
|
| 742 |
Tirzepatide
|
|
664 KB
|
| 743 |
Oral AUR105
|
|
2312 KB
|
| 744 |
Durvalumab plus Domvanalimab (AB154
|
|
684 KB
|
| 745 |
Capivasertib + Docetaxel
|
|
657 KB
|
| 746 |
Cefepime Zidebactam vs. Meropenem
|
|
661 KB
|
| 747 |
Biphasic Insulin Aspart Injection IP 100 IU/mL
|
|
700 KB
|
| 748 |
Novel Corona virus-2019-nCoV Vaccine
|
|
572 KB
|
| 749 |
Tremelimumab ± Lenvatinib
|
|
676 KB
|
| 750 |
IcoSema and once weekly insulin icodec
|
|
687 KB
|
| 751 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin film coated tablets (Phase III)
|
|
192 KB
|
| 752 |
Linagliptin + Dapagliflozin tablets (Phase III)
|
|
260 KB
|
| 753 |
Bucillamine tablets 100mg
|
|
2592 KB
|
| 754 |
Omalizumab Injection
|
|
693 KB
|
| 755 |
Triamcinolone Hexacetonide Injectable Suspension 20 mg/ml
|
|
2426 KB
|
| 756 |
Vildagliptin (SR) + Pioglitazone Hydrochloride IP film coated bilayered tablets (Phase III)
|
|
206 KB
|
| 757 |
Tofacitinib Ointment 2%
|
|
491 KB
|
| 758 |
Virion Inactivated Corona Virus Vaccine
|
|
320 KB
|
| 759 |
Teriperatide Injection solution for injection in a pre-filled pen 600mcg/2.4ml (Synthetic Origin)
|
|
538 KB
|
| 760 |
Omalizumab 150 mg/ml
|
|
560 KB
|
| 761 |
EMPAgliflozin
|
|
800 KB
|
| 762 |
Dapagliflozin Propanedilol Monohydrate eq. to Dapagliflozin + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin Film Coated Tablets (Phase III)
|
|
294 KB
|
| 763 |
Pregabalin IP (As Prolonged Release) + Etoricoxib IP film coated bilayered tablets (Phase IV)
|
|
309 KB
|
| 764 |
Lyka Labs
|
|
426 KB
|
| 765 |
Metformin Hydrochloride IP (as sustained release) + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated bilayered tablets (Phase III)
|
|
291 KB
|
| 766 |
Glycopyrrolate IP eq. to Glycopyrronium _+ Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumarate + Budesonide inhalation powder (Phase IV)
|
|
319 KB
|
| 767 |
HRF-10071, Tenofovir, Dolutegravir
|
|
2031 KB
|
| 768 |
Ajanta Pharma
|
|
365 KB
|
| 769 |
f GSK S. aureus candidate vaccine
|
|
673 KB
|
| 770 |
CSJ117
|
|
651 KB
|
| 771 |
CSJ117
|
|
651 KB
|
| 772 |
Glimepiride IP + Metformin Hydrochloride IP + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (Phase II
|
|
275 KB
|
| 773 |
Nor-ursodeoxycholic acid
|
|
2242 KB
|
| 774 |
Sitagliptin Phosphate IP eq. to Sitagliptin + Dapagliflozin tablets (Phase III)
|
|
293 KB
|
| 775 |
MS/ Veeda
|
|
2124 KB
|
| 776 |
HRF-10071, Tenofovir alafenamide and Emtricitabin
|
|
2148 KB
|
| 777 |
HRF-10071, Tenofovir alafenamide and Ripivirine
|
|
2175 KB
|
| 778 |
HRF-10071, Ripivirine
|
|
2165 KB
|
| 779 |
AUR103 Calciumin
|
|
2392 KB
|
| 780 |
Chlorthalidone IP + Efonidipine Hydrochloride Ethanolate IP tablets (Phase III)
|
|
266 KB
|
| 781 |
Human Insulin Short acting
|
|
706 KB
|
| 782 |
Varicella Vaccine Live, Attenuated IP(VARIVAX) 2000 PFU
|
|
146 KB
|
| 783 |
Paltusotine
|
|
674 KB
|
| 784 |
Insulin Glargine (r-DNA origin) Injection 100 units/mL
|
|
702 KB
|
| 785 |
Glimepiride IP + Metformin Hydrochloride IP + Sitagliptin Phosphate Monohydrate IP Tablets (Phase III)
|
|
319 KB
|
| 786 |
Dapagliflozin + Teneligliptin Hydrobromide Hydrate IP eq. to Dapagliflozin (Phase III)
|
|
248 KB
|
| 787 |
concizumab prophylaxis
|
|
653 KB
|
| 788 |
Elobixibat
|
|
2497 KB
|
| 789 |
LL-BMT1
|
|
652 KB
|
| 790 |
SCO-120
|
|
487 KB
|
| 791 |
Fosravuconazole capsules
|
|
2338 KB
|
| 792 |
Linaclotide Capsules
|
|
2258 KB
|
| 793 |
Umifenovir Tablet
|
|
2240 KB
|
| 794 |
Brinzolamide IP + Timolol Maleate IP eq. to Timolol + Potassium Sorbate IP (as preservative) Ophthalmic suspension (Phase IV)
|
|
308 KB
|
| 795 |
Silodosin + Tdalafil IP hard gelatin capsule (Phase III)
|
|
277 KB
|
| 796 |
Montelukast Sodium IP eq. to Montelukast + Bilastine Orodispersible tablet (Phase IV)
|
|
301 KB
|
| 797 |
Atrasentan
|
|
662 KB
|
| 798 |
Inactivated Influenza Vaccine (Split Virion) I.P. (Tetravalent)
|
|
330 KB
|
| 799 |
Savolitinib plus Durvalumab
|
|
806 KB
|
| 800 |
TOPOTECAN AND CYCLOPHOSPHAMIDE
|
|
653 KB
|
| 801 |
IRINOTECAN AND TEMOZOLOMIDE
|
|
653 KB
|
| 802 |
Tislelizuma
|
|
673 KB
|
| 803 |
MYL-1701P
|
|
655 KB
|
| 804 |
Naftifine hydrochloride cream 2% b
|
|
2544 KB
|
| 805 |
LY3484356
|
|
669 KB
|
| 806 |
ASLAN004
|
|
672 KB
|
| 807 |
Efonidipine Hydrochloride Ethanolate IP + Telmisartan IP film coated tablets (Phase III)
|
|
290 KB
|
| 808 |
Polmacoxib Capsules
|
|
3066 KB
|
| 809 |
osimertinib
|
|
707 KB
|
| 810 |
Semaglutide on functional capacity
|
|
652 KB
|
| 811 |
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (13- valent)
|
|
588 KB
|
| 812 |
AUR-101
|
|
2296 KB
|
| 813 |
TK-90M/s. SiRO
|
|
627 KB
|
| 814 |
Pegfilgrastim
|
|
674 KB
|
| 815 |
GRC 54276
|
|
2658 KB
|
| 816 |
Sitagliptin Phosphate monohydrate eq. to Sitagliptin IP + Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin film coated tablets (Phase III)
|
|
366 KB
|
| 817 |
HGCO19 Lyophilized mRNA Vaccine for Injection
|
|
568 KB
|
| 818 |
Denosumab
|
|
700 KB
|
| 819 |
Hepatitis A (Live) Vaccine, Freeze-Dried
|
|
497 KB
|
| 820 |
Pneumococcal Polysaccharide Conjugate Vaccine
|
|
327 KB
|
| 821 |
Inactivated Salk Polio Vaccine
|
|
333 KB
|
| 822 |
Metformin Hydrochloride IP (as sustained release) + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin + Dapagliflozin tablets (Phase III
|
|
306 KB
|
| 823 |
TK-90
|
|
626 KB
|
| 824 |
A vector vaccine for the prevention of the coronavirus infection
|
|
302 KB
|
| 825 |
Belantamab Mafodotin (GSK2857916)
|
|
649 KB
|
| 826 |
SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine [COVOVAX]
|
|
300 KB
|
| 827 |
Sodium Hyaluronate BP + Chontroitin Sulfate Sodium BP + Poloxamer IP per 10ml oral liquid (Phase IV)
|
|
311 KB
|
| 828 |
Metformin Hydrochloride IP (as extended release) + Dapagliflozin + Teneligliptin hydrobromide Hydrate IP eq. to Teneligliptin film coated bilayered tablets (Phase III)
|
|
317 KB
|
| 829 |
SAR442168 to placebo
|
|
671 KB
|
| 830 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin film coated tablets (Phase III
|
|
326 KB
|
| 831 |
NUCALA
|
|
2527 KB
|
| 832 |
Dapagliflozin Propanediol eq. to Dapagliflozin + Sitagliptin Phosphate monohydrate IP eq. to to Sitagliptin film coated tablet (Phase III)
|
|
320 KB
|
| 833 |
Vildagliptin (as sustained release) + Pioglitazone Hydrochloride eq. to Pioglitazone IP uncoated bilayered tablets (Phase III)
|
|
304 KB
|
| 834 |
Sun Pharma
|
|
416 KB
|
| 835 |
CRIZOTINIB
|
|
422 KB
|
| 836 |
Revefenacin
|
|
2350 KB
|
| 837 |
Chlorpheniramine Maleate IP + Noscapine IP per 5ml oral liquid (Phase III)
|
|
392 KB
|
| 838 |
Vildagliptin (as sustained release) + Dapagliflozin (100mg+5mg & 100mg + 10mg) tablets (Phase III)M/s. Ravenbhel Healthcare Pvt. Ltd
|
|
281 KB
|
| 839 |
Teriparatide
|
|
545 KB
|
| 840 |
Sun Pharma
|
|
505 KB
|
| 841 |
Vildagliptin (as sustained release form) + Metformin Hydrochloride (as sustained release form) IP uncoated bilayered tablets (Phase III)
|
|
290 KB
|
| 842 |
Pegfilgrastim Solution for Injection
|
|
393 KB
|
| 843 |
Remogliflozin Etabonate + Vildagliptin + Metformin Hydrochloride IP Film coated tablet (Phase IV)
|
|
329 KB
|
| 844 |
TOFACITINIB
|
|
663 KB
|
| 845 |
Whole Virion Inactivated Corona Virus Vaccine
|
|
337 KB
|
| 846 |
Tamsulosin Hydrochloride IP (as prolonged release pellets) + Tadalafil IP (as film coated tablet) capsules (Phase IV)
|
|
352 KB
|
| 847 |
ELRANATAMAB
|
|
665 KB
|
| 848 |
Teneligliptin IP + Dapagliflozin tablets (Phase III)
|
|
271 KB
|
| 849 |
AT-752
|
|
787 KB
|
| 850 |
dupilumab
|
|
667 KB
|
| 851 |
Nitazoxanide Tablets 500 mg
|
|
656 KB
|
| 852 |
Lifeviro treat inhalation
|
|
2497 KB
|
| 853 |
Atropine Sulphate Ophthalmic Solution 0.05% w/v0.05 % w/v Ophthalmic Solution
|
|
466 KB
|
| 854 |
Acalabrutinib1
|
|
665 KB
|
| 855 |
Metoprolol IP + Chlorthalidone IP + Cilnidipine IP tablets (Phase III)
|
|
276 KB
|
| 856 |
Follicle Stimulating Hormone (Human Recombinant)
|
|
564 KB
|
| 857 |
BI 690517
|
|
677 KB
|
| 858 |
SAR442168
|
|
849 KB
|
| 859 |
Abrocitinib
|
|
30383KB
|
| 860 |
Imeglimin tabletsv
|
|
2952 KB
|
| 861 |
tofacitinib
|
|
390 kB
|
| 862 |
SATRALIZUMAB
|
|
653 KB
|
| 863 |
secukinumab (Cosentyx)
|
|
661 KB
|
| 864 |
SAR443122
|
|
674 KB
|
| 865 |
Aflibercept
|
|
712 KB
|
| 866 |
alteplase
|
|
671 KB
|
| 867 |
Elranatamab (PF-06863135
|
|
670 KB
|
| 868 |
fitusiran prophylaxis
|
|
657 KB
|
| 869 |
Picrorhiza kurroa
|
|
2654 KB
|
| 870 |
Intraversial SN-38 Lipid Suspension
|
|
2587 KB
|
| 871 |
ligelizumab (QGE031)
|
|
664 KB
|
| 872 |
Intravenous Allogeneic Mesenchymal
|
|
654 KB
|
| 873 |
Amlodipine Besylate IP eq. to Amlodipine + Azilsartan Kamedoxomil eq. to Azilsartan Medoxomil tablets (Phase III)
|
|
316 KB
|
| 874 |
fluticasone propionate
|
|
771 KB
|
| 875 |
Tofacetinib Gel 2%
|
|
425 KB
|
| 876 |
hydrogen peroxide
|
|
509 KB
|
| 877 |
Mirikizumab
|
|
411 KB
|
| 878 |
Dapagliflozin + Sitagliptin film coated tablet (Phase III)M/s. Glenmark Pharmaceuticals Ltd
|
|
286 KB
|
| 879 |
Dapagliflozin + Sitagliptin film coated tablet (Phase IIIg
|
|
286 KB
|
| 880 |
Tranexamic Acid Spray 10% w/v Acid Spray 10% w/v Acid Spray 10% w/v
|
|
394 KB
|
| 881 |
SAR442168 to teriflunomide (Aubagio®)
|
|
663 KB
|
| 882 |
Mepolizumab
|
|
325 KB
|
| 883 |
Naftifine hydrochloride cream 2%
|
|
2682 KB
|
| 884 |
Dapagliflozin + Metformin Hydrochloride IP + Vildagliptin film coated tablets (Phase III)
|
|
297 KB
|
| 885 |
Imeglimin tablets
|
|
2592 KB
|
| 886 |
Quadrivalent Meningococcal Conjugate Vaccine
|
|
667 KB
|
| 887 |
Pimavenserin Capsules
|
|
2375 KB
|
| 888 |
Bioactive concentrate from small marine fish + water for injection (WFI) solution for injection (Phase III)
|
|
296 KB
|
| 889 |
Chimpanzee Adenovirus Vectored COVID-19 Vaccine (BBV154)
|
|
232 KB
|
| 890 |
Vildagliptin SR + Dapagliflozin + film coated bilayered tablets (Phase III)
|
|
286 KB
|
| 891 |
Chimpanzee Adenovirus Vectored COVID-19 Vaccine
|
|
424 KB
|
| 892 |
Ferric Pyrophosphate citrate
|
|
2622 KB
|
| 893 |
Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5
|
|
659 KB
|
| 894 |
tocilizumab
|
|
653 KB
|
| 895 |
Nano Carrier Entrapped Vitamin D3 Oral Dispersion 60000IU
|
|
490 KB
|
| 896 |
Vildagliptin + Dapagliflozin + Metformin hydrochloride IP tablets (Phase III)
|
|
341 KB
|
| 897 |
PROphylaxis
|
|
347 KB
|
| 898 |
(r-hFSH) 900 IU (66.0 μg)/1.5 mL Solution
|
|
657 KB
|
| 899 |
Dapagliflozin + Metformin XR versus Metformin XR
|
|
548 KB
|
| 900 |
PCV-20 Valent
|
|
556 KB
|
| 901 |
IMM-101
|
|
654 KB
|
| 902 |
LXE408
|
|
652 KB
|
| 903 |
Wosulin R, Wosulin N and Wosulin 30/70
|
|
742 KB
|
| 904 |
Anifrolumab
|
|
657 KB
|
| 905 |
Amantadine Extended Release Tablet 129/193 mg
|
|
446 KB
|
| 906 |
INO-4800
|
|
685 KB
|
| 907 |
IcoSema and Daily Insulin Glargine 100 units/mL
|
|
733 KB
|
| 908 |
LTX-109 3% gel
|
|
323 KB
|
| 909 |
BI 685509
|
|
655 KB
|
| 910 |
Dapagliflozin + Metformin Hydrochloride IP (Extended Release) + Sitagliptin Phosphate monohydrate IP eq. to Sitagliptin film coated bilayered tablets (Phase III)
|
|
331 KB
|
| 911 |
Cholera Vaccine (Inactivated, Oral), I.P.
|
|
306 KB
|
| 912 |
Pertuzumab 420 mg/14mL Injection
|
|
693 KB
|
| 913 |
MEDI3506
|
|
667 KB
|
| 914 |
Alpelisib plus Fulvestrant
|
|
2590 KB
|
| 915 |
Anti-HIV microbicide gel
|
|
2139 KB
|
| 916 |
SARS-CoV-2 (Covid-19) Vaccine (RBD antigen of SARS CoV-2(Covid-19
|
|
234 KB
|
| 917 |
Measles (Edmonston Zagreb) and Rubella (RA27/3) Vaccine Live, Attenuated (Freeze Dried), IP
|
|
329 KB
|
| 918 |
OMS721
|
|
675 KB
|
| 919 |
Mupirocin 2% w/w Ointment
|
|
428 KB
|
| 920 |
Dato-DXd
|
|
782 KB
|
| 921 |
remibrutinib LOU064
|
|
675 KB
|
| 922 |
COVID-19 (Adapt Out COVID)
|
|
748 KB
|
| 923 |
Metformin Hydrochloride IP (as prolonged release) + Teneligliptin IP + Dapagliflozin tablets (Phase III)
|
|
190 KB
|
| 924 |
Paclitaxel-Carboplatin-Oregovomab)
|
|
655 KB
|
| 925 |
Trastuzumab Deruxtecanas
|
|
771 KB
|
| 926 |
Mirabegron (As extended release) + Silodosin film coated bilayered tablets (Phase III)
|
|
184 KB
|
| 927 |
Lemborexant
|
|
23275 KB
|
| 928 |
Bempedoic acid
|
|
24271 KB
|
| 929 |
Darolutamide
|
|
2994 KB
|
| 930 |
Sitagliptin Phosphate monohydrate IP eq. to Sitagliptin + Dapagliflozin tablets (Phase III)
|
|
258 KB
|
| 931 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Glimepiride IP + Metformin Hydrochloride IP tablets (Phase III)
|
|
247 KB
|
| 932 |
Ozenoxacin Lotion 2% w/v
|
|
1196 KB
|
| 933 |
CKD-314
|
|
689 KB
|
| 934 |
Esmprazole Dual release Gastro Resistant Tablets 80 mg
|
|
515 KB
|
| 935 |
Adjuvant Giredestrant
|
|
739 KB
|
| 936 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate monohydrate IP eq. Sitagliptin + Metformin Hydrochloride IP Film coated tablet (Phase III)
|
|
234 KB
|
| 937 |
Plecanatide
|
|
23335 KB
|
| 938 |
Metoprolol Succinate IP (ER) + Azelnidipine IP film coated bilayered tablets (Phase III)
|
|
184 KB
|
| 939 |
Bilastine + Montelukast sodium IP eq. to Montelukast IP per 5ml oral suspension (Phase III)
|
|
168 KB
|
| 940 |
brequinar combined dipyridamole
|
|
657 KB
|
| 941 |
remibrutinib (LOU064)
|
|
671 KB
|
| 942 |
IMU-838 versus Placebo
|
|
656 KB
|
| 943 |
Cariprazine
|
|
2129 KB
|
| 944 |
IMU-838
|
|
657 KB
|
| 945 |
Peptide Receptor Radionuclide Therapy (PRRT)
|
|
765 KB
|
| 946 |
Typhoid Conjugate Vaccine (Monovalent) [Typhoid Vi ConjugateVaccine]
|
|
583 KB
|
| 947 |
asciminib
|
|
656 KB
|
| 948 |
dabrafenib plus trametinib
|
|
660 KB
|
| 949 |
cccc
|
|
2368 KB
|
| 950 |
INTP24 Against Avastin®
|
|
661 KB
|
| 951 |
Amivantamab and Lazertinib
|
|
668 KB
|
| 952 |
Teneligliptin IP + Rosuvastatin Calcium IP tablets (Phase III)
|
|
253 KB
|
| 953 |
Dapagliflozin + Vildagliptin tablets (Phase III)
|
|
198 KB
|
| 954 |
triptyline IP + Methylcobalamin IP + Pregabalin IP (SR) Tablets (Phase III)
|
|
231 KB
|
| 955 |
Tirzepatiden
|
|
680 KB
|
| 956 |
Trastuzumab Deruxtecan (T-DXd)
|
|
521 KB
|
| 957 |
LIB003 in Heterozygous
|
|
659 KB
|
| 958 |
Alcaftadine Nasal Spray
|
|
400 KB
|
| 959 |
Alcaftadine Nasal Spray CT NOC
|
|
404 KB
|
| 960 |
Alcaftadine Nasal Spray ALDP001
|
|
389 KB
|
| 961 |
Lastacaft
|
|
389 KB
|
| 962 |
Rilematovir (JNJ-53718678)
|
|
505 KB
|
| 963 |
CSJ117
|
|
653 KB
|
| 964 |
MSP008-22c
|
|
2128 KB
|
| 965 |
Bisoprolol Fumarate IP + Telmisartan IP uncoated bilayered tablets (Phase III)
|
|
172 KB
|
| 966 |
Zinc Citrate Trihydrate eq. to Zinc IP +Ascorbic Acid IP effervescent tablets (Phase IV)
|
|
187 KB
|
| 967 |
LIB003n
|
|
650 KB
|
| 968 |
LIB003 (Low density lipoprotein)
|
|
650 KB
|
| 969 |
Itolizumab
|
|
670 KB
|
| 970 |
Marstacimab Prophylaxis
|
|
645 KB
|
| 971 |
Pharmacokinetics of Remdesivir
|
|
2831 KB
|
| 972 |
Capmatinib film coated tablet 150 mg/200 mg
|
|
2260 KB
|
| 973 |
INO-4800
|
|
673 KB
|
| 974 |
ADG20
|
|
514 KB
|
| 975 |
Brazikumabn
|
|
665 KB
|
| 976 |
antiviral therapies
|
|
4141 KB
|
| 977 |
Proxalutamide (GT0918
|
|
518 KB
|
| 978 |
Brazikumab
|
|
666 KB
|
| 979 |
Finerenone
|
|
508 KB
|
| 980 |
Deupirfenidone (LYT-100)
|
|
501 KB
|
| 981 |
NNC0194-0499
|
|
529 KB
|
| 982 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Glimepiride IP + Metformin Hydrochloride IP (as extended release) Film coated bilayered tablets (Phase III)
|
|
245 KB
|
| 983 |
OAV101
|
|
496 KB
|
| 984 |
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (11-valent)
|
|
324 KB
|
| 985 |
Inactivated Hepatitis A Vaccine (Adsorbed
|
|
315 KB
|
| 986 |
Letrozole Tablet 5 mg
|
|
2846 KB
|
| 987 |
Brinzolamide IP + Brimonidine Tartrate IP Ophthalmic suspension (Phase III)
|
|
184 KB
|
| 988 |
Urosodiol Injection 625 mg/25ml 925mg/ml)
|
|
3072 KB
|
| 989 |
Study (NEST)
|
|
652 KB
|
| 990 |
MYL-1701P
|
|
510 KB
|
| 991 |
Intravitreal OPT-302
|
|
338 KB
|
| 992 |
Remdesivir for injection 100mg/vial
|
|
2819 KB
|
| 993 |
Typhoid Vi Conjugate Vaccine I.
|
|
232 KB
|
| 994 |
Loeglitazone sulphate 0.5 mg tablets
|
|
2617 KB
|
| 995 |
Ad26.COV2.S
|
|
664 KB
|
| 996 |
Quadrivalent Influenza vaccine (Split Virion, Inactivated)
|
|
306 KB
|
| 997 |
PF-07321332/Ritonavir
|
|
410 KB
|
| 998 |
OPT-302
|
|
672 KB
|
| 999 |
HRF-10071
|
|
2295 KB
|
| 1000 |
Vilanterol Trifenatate eq. to Vilanterol + Fluticasone Furoate per actuation delivers metered dose inhalation (Phase III)
|
|
224 KB
|
| 1001 |
Insulin Aspart Injection (100 IU/mL)
|
|
695 KB
|
| 1002 |
PDP-1 17
|
|
2303 KB
|
| 1003 |
Peg-filgrastim Injection 6 mg/0.6ml
|
|
684 KB
|
| 1004 |
ziltivekimab1
|
|
646 KB
|
| 1005 |
ISTH0036
|
|
476 KB
|
| 1006 |
FP-025
|
|
483 KB
|
| 1007 |
MRG-001,
|
|
646 KB
|
| 1008 |
Gadoteridol 279.3mg/ml Injection
|
|
2210 KB
|
| 1009 |
Anti-COVID-19 AKS-452 vaccine
|
|
671 KB
|
| 1010 |
Nortriptyline IP + Methylcobalamin IP + Pregabalin IP (SR) Film Coated Tablets (Phase III)
|
|
203 KB
|
| 1011 |
Acalabrutinibz
|
|
967 KB
|
| 1012 |
Teneligliptin Hydrobromide IP + Dapagliflozin tablets (Phase III)
|
|
131 KB
|
| 1013 |
Naltrexone Hydrochloride + Zonisamide sustained release capsules (Phase II)
|
|
242 KB
|
| 1014 |
Novel Corona virus-2019-nCoV Vaccine (recombinant)
|
|
229 KB
|
| 1015 |
Insulin Aspart Injection 100 U/mL
|
|
697 KB
|
| 1016 |
Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin
|
|
502 KB
|
| 1017 |
Varespladib-Methyl
|
|
650 KB
|
| 1018 |
Angiotensin Receptor Blocker (ARB)
|
|
651 KB
|
| 1019 |
Imetelstat (GRN163L)
|
|
514 KB
|
| 1020 |
Apremilast Topcial Gel 2%
|
|
3225 KB
|
| 1021 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP + Glimepiride IP tablets (Phase III)
|
|
230 KB
|
| 1022 |
Favipiravir Tablet 200/800 m
|
|
675 KB
|
| 1023 |
BP01 (Bevacizumab)
|
|
656 KB
|
| 1024 |
Betamethasone dipropionate Ph. Eur + Calcipotriol anhydrous Ph. Eur. Cutaneous spray (Phase III)
|
|
220 KB
|
| 1025 |
Polatuzumab Vedotin
|
|
649 KB
|
| 1026 |
unadjuvanted RSV Maternal vaccine
|
|
657 KB
|
| 1027 |
Bisoprolol IP + Telmisartan IP tablets (Phase III)
|
|
208 KB
|
| 1028 |
Bempedoic acid 180 mg tabletct
|
|
239 KB
|
| 1029 |
Secukinumab
|
|
654 KB
|
| 1030 |
Azelnidipine + Telmisartan IP tablets (Phase III)
|
|
215 KB
|
| 1031 |
Inhaled Ampion
|
|
668 KB
|
| 1032 |
Saroglitazar Tablet 4 mg
|
|
2782 KB
|
| 1033 |
Bempedoic acid 180 mg tablet
|
|
2853 KB
|
| 1034 |
Bilastine + Montelukast Sodium IP eq. to Montelukast oral suspension (Phase III)
|
|
197 KB
|
| 1035 |
Silodosin + Tadalafil capsules (Phase III)
|
|
287 KB
|
| 1036 |
Herpes Zoster vaccine
|
|
219 KB
|
| 1037 |
Tirzepatide
|
|
660 KB
|
| 1038 |
Sitagliptin Phosphate IP eq. to Sitagliptin + Pioglitazone Hydrochloride IP eq. to Pioglitazone IP + Metformin Hydrochloride IP(as sustained release) tablets (Phase III)
|
|
233 KB
|
| 1039 |
Hydroxyprogesterone Caproate Intramuscular Injection
|
|
651 KB
|
| 1040 |
Iptacopan (LNP023)
|
|
651 KB
|
| 1041 |
Dapagliflozin + Teneligliptin Hydrobromide Hydrate IP Phase III)
|
|
192 KB
|
| 1042 |
Pioglitazone Hydrochloride IP + Teneligliptin Hydrobromide Hydrate IP tablets (Phase III)
|
|
185 KB
|
| 1043 |
Indacaterol Maleate eq. to Indacaterol + Budesonide IP per actuation delivers metered dose inhaler (Phase III)
|
|
197 KB
|
| 1044 |
Indacaterol Maleate eq. to Indacaterol + Budesonide IP dry powder for inhalation (capsules) (Phase III)
|
|
207 KB
|
| 1045 |
Fesoteroduine Fumarate Extend release tabklet 4 mg/8 mg and Solifenacin sucinate tablets 5 mg/10 mg
|
|
2540 KB
|
| 1046 |
Typhoid Conjugate
|
|
567 KB
|
| 1047 |
Fimasartan Potassium + Chlorthalidone IP tablets (Phase III)
|
|
176 KB
|
| 1048 |
BP05 Versus EU-Approved Lucentis®
|
|
674 KB
|
| 1049 |
Nucleocapsid
|
|
326 KB
|
| 1050 |
Cetrelimab
|
|
689 KB
|
| 1051 |
ziltivekimab
|
|
446 KB
|
| 1052 |
Acalabrutinib
|
|
404 KB
|
| 1053 |
Favipiravir Tablet 200/400/800 mg
|
|
2852 KB
|
| 1054 |
SARS-CoV-2Vaccine
|
|
323 KB
|
| 1055 |
(KAE609)
|
|
653 KB
|
| 1056 |
Efonidipine hydrochloride Ethanolate + Telmisartan IP Film coated bilayered tablet (Phase III)
|
|
215 KB
|
| 1057 |
Amoxicillin Trihydrate 759.04 mg eq. to Amoxicillin free acid 652.78 mg* + Potassium Clavulanate 61.48 mg eq. to Clavulanic acid 50.41mg
|
|
176 KB
|
| 1058 |
Remdesivir 100 mgb
|
|
2180 KB
|
| 1059 |
Favipiravir tablet 200 mg/400 mg/800 mg
|
|
2836 KB
|
| 1060 |
Tapentadol Hydrochloride Nasal Spray 225 mg/ml
|
|
3553 KB
|
| 1061 |
Ozenoxacin Lotion 2% W/v
|
|
3467 KB
|
| 1062 |
Cipargamin
|
|
543 KB
|
| 1063 |
Atacicept
|
|
659 KB
|
| 1064 |
PTG-300
|
|
2593 KB
|
| 1065 |
Lenvatinib 4/10 mg Capsule
|
|
3239 KB
|
| 1066 |
HGCO19
|
|
313 KB
|
| 1067 |
SARS-CoV-2V
|
|
669 KB
|
| 1068 |
Recombinant Human Parathyroid Hormone (rhPTH1-34) injection (Teriparatide Injection) 750 mcg/3 mL
|
|
708 KB
|
| 1069 |
Favipiravir tablet 400 mg
|
|
2337 KB
|
| 1070 |
Vildagliptin SR + Metformin Hydrochloride (SR) uncoated bilayered tablets (Phase III)
|
|
199 KB
|
| 1071 |
Teneligliptin Hydrobromide hydrate eq. to Teneligliptin + Dapagliflozin tablets (Phase III)
|
|
170 KB
|
| 1072 |
Sitagliptin Phosphate IP eq. to Sitagliptin + Dapagliflozin tablets (Phase III)
|
|
182 KB
|
| 1073 |
Favipiravir tablet 800 mg
|
|
2285 KB
|
| 1074 |
Talazoparib With Enzalutamide
|
|
654 KB
|
| 1075 |
Remdesivir 100 mgh
|
|
2560 KB
|
| 1076 |
LNP023n
|
|
649 KB
|
| 1077 |
Metformin hydrochloride IP (as an extended-release form) + Sitagliptin Phosphate IP eq. to Sitagliptin + Dapagliflozin tablets (Phase III)
|
|
216 KB
|
| 1078 |
Remdesivir 100 mgj
|
|
2305 KB
|
| 1079 |
Cocculus hirsutus
|
|
3037 KB
|
| 1080 |
Mifepristone 10/25 mg Tablet
|
|
2861 KB
|
| 1081 |
Remdesivir 100 mgc
|
|
2484 KB
|
| 1082 |
Sputnik Light
|
|
229 KB
|
| 1083 |
Rilematovir
|
|
409 KB
|
| 1084 |
C21
|
|
409 KB
|
| 1085 |
BBV154
|
|
423 KB
|
| 1086 |
2-Deoxy-D-Glucose Oral Powder 2.34 gm & 3.0 gm
|
|
176 KB
|
| 1087 |
Teneligliptin hydrobromide hydrate eq to Teneligliptin IP + Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin film coated tablets (Phase III)
|
|
236 KB
|
| 1088 |
Remdesivir for Injection 100mg/ml
|
|
3135 KB
|
| 1089 |
Favipiravir tablet 200 mgw
|
|
2590 KB
|
| 1090 |
Semaglutide 2.4 mg
|
|
406 KB
|
| 1091 |
Remdesivir for Injection 100mg/ml
|
|
2877 KB
|
| 1092 |
Doxazosin Tablet 2 mg
|
|
2638 KB
|
| 1093 |
Chimpanzee Adenovirus Vectored
|
|
276 KB
|
| 1094 |
COVAXIN
|
|
308 KB
|
| 1095 |
Atezolizumab
|
|
680 KB
|
| 1096 |
Encorafenib Plus Cetuximab
|
|
657 KB
|
| 1097 |
Remdesivir 100 mg
|
|
2480 KB
|
| 1098 |
Favipiravir tablet 200 mgf
|
|
2341 KB
|
| 1099 |
Favipiravir tablet 200 mg
|
|
2181 KB
|
| 1100 |
Favipiravir tablet 200 mgdr
|
|
2181 KB
|
| 1101 |
Favipiravirtablet 200 mg
|
|
2341 KB
|
| 1102 |
Remdesivir100 mg
|
|
248 KB
|
| 1103 |
Lidocaine Spray 10% w/v
|
|
175 KB
|
| 1104 |
VIB7734
|
|
655 KB
|
| 1105 |
Olaparib
|
|
501 KB
|
| 1106 |
EQ001
|
|
639 KB
|
| 1107 |
Niclosamidee
|
|
496 KB
|
| 1108 |
Insulin Degludec 100 units/mL
|
|
410 KB
|
| 1109 |
Duloxetine (as delayed release pellets) IP + Pregabalin IP hard gelatin capsules (Phase III)
|
|
217 KB
|
| 1110 |
ensovibep (MP0420)
|
|
530 KB
|
| 1111 |
Aspirin (EC) IP + Ticagrelor (SR) IP capsules (Phase III)
|
|
199 KB
|
| 1112 |
RP7214jss
|
|
2693 KB
|
| 1113 |
Vildagliptin SR + Metformin Hydrochloride SR IP Sustained release tablets (Phase III)
|
|
192 KB
|
| 1114 |
Azilsartan Medoxomil + Amlodipine tablets (Phase III)
|
|
286 KB
|
| 1115 |
Endoxifen
|
|
2385 KB
|
| 1116 |
RP7214
|
|
2293 KB
|
| 1117 |
Levonadifloxacinw
|
|
2474 KB
|
| 1118 |
Levonadifloxacinn
|
|
2474 KB
|
| 1119 |
CA-170
|
|
2252 KB
|
| 1120 |
imatinib mesylate
|
|
458 KB
|
| 1121 |
Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP
|
|
405 KB
|
| 1122 |
PF-07321332
|
|
506 KB
|
| 1123 |
Amikacin Sulphate
|
|
386 KB
|
| 1124 |
LIB003
|
|
498 KB
|
| 1125 |
Endoxifen2
|
|
2358 KB
|
| 1126 |
Minocycline Hydrochloride Topical Gel 4%
|
|
2674 KB
|
| 1127 |
Atropine Sulfate Ophthalmic Solution USP 0.01% w/v
|
|
706 KB
|
| 1128 |
C-TB with QuantiFERON-TB Gold Plus and 2.T.U. Tuberculin PPD RT23
|
|
2167 KB
|
| 1129 |
VPM1002 (rBCG) Vaccine
|
|
223 KB
|
| 1130 |
23-valent Pneumococcal Polysaccharide Vaccine I.P.
|
|
388 KB
|
| 1131 |
LY3471851
|
|
638 KB
|
| 1132 |
Lifitegrast
|
|
2347 KB
|
| 1133 |
Nitric oxide
|
|
2443 KB
|
| 1134 |
Dextromethorphan Polistirex eq. to Dextromethorphan Hydrobromide IP + Chlorpheniramine Polistirex eq. to Chlorpheniramine Maleate + Methylparaben IP + Propylparaben IP per 5ml sustained release oral suspension (Phase IV)
|
|
222 KB
|
| 1135 |
ofatumumab and siponimod versus fingolimod
|
|
501 KB
|
| 1136 |
EMPAgliflozin
|
|
537 KB
|
| 1137 |
Coronavirus vaccine (rDNA) â BBV151
|
|
319 KB
|
| 1138 |
Dienogest 2mg Tablet
|
|
345 KB
|
| 1139 |
Aqueous chlorine S
|
|
2399 KB
|
| 1140 |
JNJ-42756493
|
|
492 KB
|
| 1141 |
Vildagliptin (as sustained release) + Dapagliflozin tablets (Phase III)
|
|
266 KB
|
| 1142 |
Urosdexycholic Acid Tablet 150/mg/300 mg
|
|
3327 KB
|
| 1143 |
Solidarity trial
|
|
3455 KB
|
| 1144 |
Dapagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP Film coated tablet (Phase III)
|
|
233 KB
|
| 1145 |
Molnupiravir Mild2
|
|
3954 KB
|
| 1146 |
NNC0365-3769
|
|
404 KB
|
| 1147 |
Anti-Covid-19 mAbs cocktail drug product
|
|
561 KB
|
| 1148 |
OQL011
|
|
503 KB
|
| 1149 |
Hydrochloroquinee
|
|
187 KB
|
| 1150 |
Multitope Protein/ Peptide-Based SARS-CoV-2 Vaccine (Manufactured by M/s Aurobindo Pharma Limited, Hyderabad) 2. UB-612(Imported from M/s UBI Pharma (UBIP),Taiwan)
|
|
302 KB
|
| 1151 |
Metoprolol Succinate eq. to Metoprolol Tartrate IP + Azelnidipine IP tablets (Phase III)
|
|
198 KB
|
| 1152 |
Erdafitinib
|
|
497 KB
|
| 1153 |
Flupentixol + Melitracen tablets (Phase IV)
|
|
139 KB
|
| 1154 |
Montelukast Sodium IP eq. to Montelukast + Bilastine orodispersible tablet (Phase III)
|
|
190 KB
|
| 1155 |
Fluticasone Furoate + Umeclidinium Bromide + Vilanterol Trifenatate powder for inhalation (Phase IV)
|
|
201 KB
|
| 1156 |
ZY-19489
|
|
2106 KB
|
| 1157 |
ZYIL 1
|
|
2179 KB
|
| 1158 |
GRC 17536
|
|
2255 KB
|
| 1159 |
PNB-001
|
|
2870 KB
|
| 1160 |
AB1001
|
|
2037 KB
|
| 1161 |
ODM-203
|
|
2225 KB
|
| 1162 |
MKP-10241
|
|
2162 KB
|
| 1163 |
SARS-CoV-2 Adjuvanted Recombinant
|
|
505 KB
|
| 1164 |
Duloxetine Hydrochloride eq. to Duloxetine (as gastro resistant pellets) IP + Pregabalin IP Capsules (Phase III)
|
|
215 KB
|
| 1165 |
Quercetin Nutraceutical bar
|
|
2159 KB
|
| 1166 |
Anti-COVID19 Serum [Equine Anti Covid Antibody Fragments F(abâ)2]
|
|
292 KB
|
| 1167 |
Gam-COVID-Vac combined vector vaccine Component Iand Component II
|
|
229 KB
|
| 1168 |
Molnupiravir Mildapl
|
|
2404 KB
|
| 1169 |
Molnupiravir Moderateapl
|
|
2472 KB
|
| 1170 |
Palbociclib versus Anastrozole
|
|
326 KB
|
| 1171 |
Bilastine Tablets 40mg
|
|
3789 KB
|
